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Introduction 
 
The today’s growing world population requires the earth to produce more sufficient and safety food 
to feed the entire world. In this context, food and feed safety play an important role for both animal 
and human being to assure that they are toxin free for consumption. Even though, toxigenic fungi 
often grow on edible plants, thus grains and processed grains which are used as food or feed stuffs 
often contaminated with mycotoxins worldwide. This contamination can occur due to inappropriate 
agricultural practice, storage and the climate change. As a result, common mycotoxin-contaminated 
agricultural commodities are of potential concerns for human and animal health when unintentional 
ingestion or once those stuffs heavily contaminated, destroy action must be taken that lead to 
economic loss. 
 
Chapter I: General background and objective of the work 
 
1.1. Context of the study 
 
The contaminants in food, feed, drinking water and environment resulting from industrial, 
agricultural practices or climate changes, and occurring either as single or as mix forms, raise 
concerns for adverse effects after long-term and low-doses exposure. Generally, human and animals 
are exposed to these compounds primarily via food, and consequently intestinal tissue is the first 
physiological barrier tissue potentially highly exposed to these contaminants (Pinton and Oswald 
2014; Bouhet and Oswald 2005). Among the major contaminants, mycotoxins, the natural food/feed 
contaminants, can represent an important risk factor for human and animal health. After ingestion, 
mycotoxins will cause lowered performance, induce various pathologies on humans and animals 
depending on the type, duration and level of exposure. However, the signs are not directly 
recognized in relation to mycotoxins due to their effects on the immune system, the gut barrier or 
the oxidative status of the animals (Pestka and Smolinski 2005; Pestka et al. 2004). 
 
1.1.1. Mycotoxins 
 
Mycotoxins are toxic secondary metabolites produced by fungi in response to stress although they 
are not essential to fungal growth. They can occur before or under post-harvest conditions, and that 
up to 72% of one mycotoxin and to 38% of co-contamination with two or more mycotoxins in 
agricultural commodities, particularly cereals and grains had been found to be contaminated 
worldwide which result in potential deterioration of human and animal health (Streit et al. 2013; 
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Schatzmayr and Streit 2013; Wild and Gong 2010; Rai and Varma 2010; Oswald et al. 2005). They 
are mainly produced by fungi in the Aspergillus, Penicillium and Fusarium genera. More than 300 
mycotoxins are identified, and this number is increasing, especially because of the masked 
mycotoxins, plant metabolites or food processes of mycotoxins and emerging mycotoxins, not 
routinely determined mycotoxins. Among those, the major produced mycotoxins and the most often 
occurring mycotoxins, particularly in swine feed, are aflatoxins, ochratoxins (A) fumonisins, 
zearalenone and  trichothecenes i.e. deoxynivalenol (Berthiller et al. 2013; Galaverna et al. 2009; 
Creppy 2002; Miller 1998). The trichothecence mycotoxins are extremely prevalent and broadly 
produced by Fusarium genus, the genus that is capable of forming a variety of secondary 
metabolites (Pinton and Oswald 2014). The trichothecenes are divided into two groups: Type A, 
including T-2 toxin, HT-2 toxin, neosolaniol and diacetoxyscirpenol (DAS), while the Type B 
including fusarenon-X (FUS-X), nivalenol (NIV) and deoxynivalenol (DON) and its 3-acetyl and 
15-acetyl derivatives (3- and 15-ADON). The limit levels of DON of 0.2 to 1.75 mg/kg are for 
cereals and derived products for the human consumer. In feed, the maximum levels depend on the 
species, from 0.9 to 5 mg/kg for complementary and complete feedstuffs have been recommended 
(EC 2006). NIV has also been established a tolerable daily intake (TDI) of 1.2 µg/kg b.w. per day in 
grains and grain-based foods for human while the concerns in animal remained underestimated 
(EFSA 2013). 
 
Co-occurrence of DON and NIV has been shown in grains and grain products; with DON usually 
present at higher concentrations than NIV (Rasmussen et al. 2003). Recently, mycotoxins 
contaminated maize in South-East of France has been reported with 100% and those with more than 
one mycotoxins (Trichothecenes, zearalenone, fumonisins) (Airfaf 2015). A large scale data survey 
has indicated that DON and NIV are present in 57% and 16%, respectively, of food samples 
collected in the European Union (Schothorst and van Egmond, 2004). This occurrence brought up a 
concern for European Commission. In consequence, EFSA was asked to assess the co-occurrence of 
nivalenol with deoxynivalenol in feed and food, as signs of toxicity in animal (pigs) can be 
observed (EFSA 2013). Therefore, our study has been designed to give scientific data contributing 
to human or animal risk health assessment of DON and NIV. 
 
1.1.2. Pig intestine as a target for DON and NIV 
 
Pig is the most sensitive species to DON followed by rodent > dog > cat > poultry >ruminants 
(Pestka and Smolinski 2005) also a species suggested by European Commission (EC 2000) to be 
sensitive to NIV. Pig digestive physiology is very similar to human (Kararli 1995), and this species 
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can be regarded as the most relevant animal model for extrapolating to human (Rothkötter et al. 
2002; Nejdfors et al. 2000; Rotter et al. 1996). Following the ingestion of contaminated food/feed or 
toxic chemicals, the gastrointestinal tract intrinsically able to resist or regulate those stuffs. Its 
principal functions when subject to those contaminants include storage, propulsion, digestion, 
absorption, secretion, barrier activity and elimination (Haschek et al. 2010). Small intestine, a 
segment of gastrointestinal tract, responsible for secretion and absorption of nutrient (95%), water 
uptake regulations and moreover, the intestinal epithelium acts as a selective and effective barrier to 
biotransforms xenobiotics, exclusion of potential pathogens in luminal contents (bacteria and 
nonabsorbed compounds) out of the body (Gelberg 2012; Vereeke et al. 2011; Haschek et al. 2010; 
Oswald 2006). Small intestinal mucosa morphology consists of surface epithelium, crypts/glands, 
lamina propria, and a thin layer of muscle separating the mucosa and submucosa. It can be 
artificially divided into two zones: villi for absorptive and enzyme release functions; and crypts for 
secretion and replacement (Haschek et al. 2010). 
 
The intestinal epithelium is a specialized monolayer of columnar cells lining the gut lumen (Fig.1). 
Four main types of differentiated cell types are present: goblet cells, Paneth’s cells, enterocytes and 
enteroendocrine cells with multi-functional roles as the most crucial role of barrier to the passage 
from the external environment into the organism (van der Flier and Clevers 2009; Groschwitz and 
Hogan 2009). The process of cell shedding under homeostatic conditions must be tightly regulated 
to preserve the integrity of the intestinal barrier, and proliferative regeneration after cytotoxic 
damage, appear to originates at crypt site (Vereeke et al. 2011; Booth and Potten 2000). Meanwhile, 
different cellular outputs from a crypt and induction of the stem cells to favor the forms of 
differentiation, displacement or apoptosis may be required due to the changes in the tissue 
environment (Booth and Potten 2000). Apoptosis is an organized process of programmed cell death. 
A process of apoptosis that is induced by a loss of anchorage, is seen as the main mechanism by 
which epithelial cells are eliminated at the villus tip. The epithelial proliferation and turnover, under 
inflammatory conditions (Vandenbroucke et al. 2011, Bracarense et al. 2012), are accelerated, result 
in increasing the risk of barrier leakage. 
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Figure 1. Schematic overview of the crypt-villus architecture and the cellular composition of the 
small intestine. Adapted from Zachary and McGavin (2012) and Vereecke et al. (2011) 
 
 
1.1.3. Sensitive biomarkers of mycotoxins in small intestine 
 
Pig intestinal epithelial cells serve as a dynamic barrier. An increasing number of studies suggest 
that they are targets for deoxynivalenol (DON) and other Type B trichothecenes (Pinton et al. 2009; 
Pinton and Oswald 2014; Hooper and Macpherson 2010), and for testing the effects of mycotoxins 
(Table 1.). The jejunum is selected for this study because it is the most absorptive part (95% of 
nutrient absorption), with the highest villi, and the longest segment of the small intestine (Gelberg 
2012; Haschek et al. 2010) (Fig. 2.). Several endpoints can be used as biomarkers of toxicity and 
have been described with DON and other trichothecenes (Table 2.). 
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Figure 2. Schematic diagram of the topographic histology of the digestive tube, adapted from 
Gelberg (2012) 
 
Table 1. 
Pig digestive effects induced by DON, NIV and other trichothecenes 
Modes Segment Toxins Concentrations Effects References 
In vivo 
Jejunum, 
ileum 
DON 
1.5 mg/kg feed; 
4 weeks 
Induced atrophy, induced 
histological lesions; decreased 
villus height in jejunum; 
reduced crypt depth in jejunum 
and ileum 
Gerez et al. 2015 
In vivo Jejunum DON 2.3 mg/kg feed; 
5 weeks 
Induced histological lesions Lucioli et al. 2013 
In vivo 
Jejunum, 
ileum 
DON 
4 mg/kg feed; 
30 days 
Enhanced permeability; 
damaged villi   
Xiao et al. 2013 
In vivo 
Jejunum, 
ileum 
DON 
3 mg/kg feed; 5 
weeks 
Induced atrophy; fused and 
decreased villi height  
Bracarense et al. 
2012 
In vivo Jejunum DON 3 mg/kg feed; 
10 weeks 
Increased crypt depth 
Dänicke et al. 
2012 
In vivo Jejunum DON, 15-
ADON 
2.29 mg/kg 
feed; 4weeks 
Induced atrophy, histological 
lesions;  fused villi, necrosis 
Pinton et al. 2012 
In vivo intestines NIV 2.5, or 5 mg/kg; Gastrointestinal erosions Hedman et al. 
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3 weeks 1997 
Ex vivo 
Jejunal 
explant 
ENN, T-2 0.3–30 nM; 4h 
Induced histological lesions; 
cubic epithelial cells; induced 
cellular debris, lysis of villi 
and oedema in the lamina 
propria 
Kolf-Clauw et al. 
2013 
Ex vivo 
Jejunum 
explant 
DON, 3-
ADON 
15-
ADON 
10 µM; 4h 
Induced histological lesions, 
lyses of enterocytes; flattened 
and coalescent villi 
Pinton et al. 2012 
Ex vivo 
Jejunal 
explant  
DON 
0.2-5 µM; 4h 
and 8h 
Flattened and coalesced villi; 
edema and necrosis in the 
lamina propria; pyknotic 
nuclei in enterocytes 
Kolf-Clauw et al. 
2009 
 
 
Effects on proliferation and apoptosis have been described in vivo, ex vivo and in vitro (Table 2.). 
The biomarker endpoints used here were Ki-67 and Caspase-3 for jejunal epithelial cell 
proliferation and apoptosis, respectively. The Ki-67 was suggested and reported as a reliable marker 
of mitosis because it is expressed during mitosis in all mammalian species from rodents to humans, 
and its half-life is very short. Moreover, it is an endogenous marker that does not have any adverse 
effects on living cells (Markovits et al. 2013; Kee et al. 2002; Scholzen and Gerdes 2000; Endl and 
Gerdes 2000). It is reported that one of the most important biochemical markers of apoptosis is 
activation of caspase-3. Besides, a central event in the process of apoptosis is the activation of the 
death protease caspase-3, and protease assays are mostly used to measure caspase-3 activity in the 
lysate of a whole population of treated cells. Consequenly, the caspase-3 is considered to play a 
pivotal role at the final step producing DNA fragmentation in the process of apoptosis (Werner and 
Steinfelder 2008; Budihardjo et al. 1999; Arends and Wyllie 1991). 
 
Table 2. 
Small intestinal and cellular proliferation and apoptosis from different modes of mycotoxin exposures 
Modes Cells Toxins Concentrations Effects References 
In vivo 
Pig jejunum, 
ileum 
DON 
4 mg/kg feed; 
37 days 
Inhibited cell 
proliferation 
Wu et al. 2014 
In vivo 
Pig jejunum, 
ileum 
DON 
4 mg/kg feed; 
30 days 
Epithelial cell 
proliferation 
Xiao et al. 2013 
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In vivo 
Pig jejunum, 
ileum 
DON 
3 mg/kg feed; 5 
weeks 
Epithelial apoptosis; 
Decreased 
proliferation in crypt 
Bracarense et al. 
2012 
Ex vivo 
Pig jejunal 
explant 
T-2 0.3–10 nM; 4h 
Decreased epithelial 
cell proliferation 
Kolf-Clauw et al. 
2013 
Ex vivo Pig jejunum DON 10 µM; 4h Induced apoptosis Pinton et al. 2012 
Ex vivo 
Pig jejunal 
explant 
DON 
0.2-5 µM; 4h 
and 8h 
Apoptotic cells in 
lamina propria 
Kolf-Clauw et al. 
2009 
In vitro Rat IEC-6 DON, NIV 0.5–80 µM; 24h 
Apoptosis, NIV 
greater than DON 
Bianco et al. 2012 
In vitro 
J774A.1 murine 
macrophages 
DON, NIV 10-100 µM; 24h 
Apoptosis, NIV 
greater than DON 
Marzocco et al. 
2009 
 
 
1.2. Mycotoxin outbreak in animal feed (book chapter)  
 
The book chapter was accepted to publish in Carol A. Wallace and Louise J. Manning, editors. 
Foodborne diseases: Case studies of outbreaks in agri-food industries. The CRC Press, UK; 2015? 
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Introduction 
 
In recent years, the occurrence of mycotoxins is increasing in food and feed especially because of new 
technologies such as the production of bioethanol and biodiesel, and the increasing availability of new by-
products suitable for inclusion in animal feeds from these technical processes. For example, distillers dried 
grains are known to contain unexpected high concentrations of mycotoxins (EFSA 2012). Climate change 
trends could affect fungal infection of crops and the degree of mycotoxin production particularly resulting in 
higher pre-harvest levels of mycotoxins. This poses both economic and health risks (Wu et al. 2011). 
 
Mycotoxins, secondary metabolites produced by fungi, have been found to contaminate up to 72% of one 
mycotoxin and 38% of co-contamination with two or more mycotoxins in agricultural commodities 
(n=17,316) worldwide, particularly cereals and grains, resulting in potential deterioration of human and 
animal health (Streit et al. 2013; Schatzmayr and Streit 2013; Wild and Gong 2010; Rai and Varma 2010; 
Oswald et al. 2005). The remaining forms of extractable conjugated or non-extractable bound mycotoxins 
are present in the plant tissue, but are currently neither routinely screened for in food nor regulated by 
legislation, thus they may be considered as “masked” as the analysis of the mycotoxin content of samples 
containing these compounds leads to their underestimation (Berthiller et al. 2013). Meanwhile, there are a 
number of mycotoxins that either have a low incidence or are unknown that may (re-) emerge or be (re-) 
introduced into the food chain (Van der Fels-Klerx et al. 2009). Furthermore, mycotoxin co-occurrence, in 
particular the interaction effects, could impact animal health at already low doses (Streit et al. 2012). 
Following the findings and reports, the European Food Safety Authority (EFSA) has raised concern for both 
human and animal health. The toxicological syndromes in human, caused by ingestion of mycotoxins, 
include growth impairment, induction of cancer (Bryden 2007), impaired intestinal health and pathogen 
fitness, resulting in altered host pathogen interactions (Antonissen et al. 2014) and decreased resistance to 
infectious diseases (CAST 2003). The Fusarium contamination of cereals and related products also causes 
feed-borne intoxication especially in farm animals (Fink-Gremmels and Malekinejad 2007). 
 
1. Mycotoxin Occurrence 
1.1 Origins of Mycotoxin and Occurrence 
 19 
1.1.1 Fungal Species 
 
The fungal species (Table 1-1) most often implicated in the field cases of mycotoxicoses belong to the 
Aspergillus, Alternaria, Claviceps, Fusarium, Penicillium and Stachybotrys genera (Milićević et al. 2010). 
Other genera including Chaetomium, Cladosporium, Diplodia, Myrothecium, Phoma, Phomopsis, 
Pithomyces also contain mycotoxic fungi (Moss 1991). Aspergillus, Fusarium and Penicillium are the genera 
of most concern, particularly in Europe, (Creppy 2002; Miller 1998). The major toxins (Figure 1-1) produced 
by these three genera include aflatoxins, ochratoxins, trichothecenes, zearalenone (ZEA) and fumonisins 
(Miller 1998). Bayman and co-workers (2002) reported various metabolites of different species of 
Aspergillus, including A. alliaceus, A. auricomus, A. carbonarius, A. ochraceus, A. glaucus, A. melleus, and 
A. niger that belong to ochratoxin family. The most important toxigenic Fusarium species occurring in grains 
and animal feedstuffs are F. culmorum, F. equiseti, F. graminearum, F. langsethiae, F. moniliforme, F. poae 
and F. sporotrichioides. A variety of Fusarium fungi, that are common soil fungi, are routinely found on 
cereals grown in the temperate regions of America, Europe and Asia. They produce a number of different 
mycotoxins of the class of trichothecenes in addition to ZEA. Trichothecene mycotoxins can be classified 
into two types: Type A including T-2 toxin and HT-2 toxin, diacetoxyscirpenol (DAS) and neosolaniol, and 
Type B including deoxynivalenol (DON), nivalenol (NIV) and fusarenon X (FX) as determined by Sugita-
Konsihi and Nakajima (2010) and Creppy (2002). Fusarium toxins have been shown to cause a variety of 
toxic effects in both experimental animals and livestock. 
[Insert Table 1-1 here] 
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Table 1-1. Mycotoxin occurrences found on cereal grains, their fungal species and clinical signs in farm animals (pig, poultry, ruminants 
and horse) 
Mycotoxins Fungal species 
Cereal/food 
commodity 
Mycotoxicosis Clinical signs 
Aflatoxins (B) 
Aspergillus 
 flavus, 
Aspergillus 
parasticus 
Barley, 
maize, rice, 
sorghum, 
wheat 
Aflatoxicosis 
Mortality, hemorrhage, liver damage, reduced productivity, increased 
susceptibility to disease, immunosuppression, inferior egg shell and 
carcass quality, demineralization, weight loss 
Deoxynivalenol Fusarium sp. 
Barley, 
maize, oats, 
wheat 
Fusariotoxicosis, 
mouldy corn toxicosis 
Immunosuppression, hepatic lesions, ovary damage, hemorrhage, beak 
and mouth necrosis, digestive-mucosa ulceration, ataxia, decreased egg 
production,  decreased feed intake and weight gain 
Fumonisins (B1) 
Fusarium 
vericilloides 
(moniliforme, 
F. proliferatum 
Maize 
Porcine pulmonary 
edema (PPE); Equine 
leukoencephalomalacia 
(ELEM) 
Respiratory distress and cyanosis (PPE), neurotoxicity (ELEM),  
hepatotoxicity, nephrotoxicity, cardiotoxicity, decreased feed intake, 
depression, ataxia, blindness, hysteria 
Ochratoxin A 
Penicillium 
verrucosum 
Barley, Rye, 
wheat 
Porcine nephropathy 
Mainly affects proximal tubules of the kidneys in pigs and poultry; 
kidneys are grossly enlarged and pale; fatty livers in poultry, hepatic 
lesions, mouth lesions, diarrhea, digestive-mucosa ulceration, ataxia, feed 
refusal, demineralization, decreased egg production 
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Zearalenone 
Fusarium 
graminearum 
Barley, 
maize, 
wheat 
Hyperestrogenism 
Immunosuppression, embryonic mortality, swollen, reddened vulva, 
reduced fertility, vaginal prolapse and sometimes rectal prolapse in pigs; 
suckling piglets may show enlargement of vulvae; bind to estrogen 
receptors, causing functional and morphologic changes in the responsive 
reproductive organs 
Adapted from Wawrzyniak and Waskiewicz (2014); Bryden, (2012); Sugita-Konsihi and Nakajima (2010); Milićević et al. (2010) 
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[Insert Figure 1-1 here] 
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Figure 1-1. Chemical structures of the main occurring mycotoxins in animal feed 
 
In addition to Aspergillus and Fusarium, Penicillium species have been reported to produce a variety of 
mycotoxins or toxic metabolites such as P. citrinum; producing citrinin,  P. verrucosum; producing 
ochratoxin, P. patulum or P. urticae or P. griseofulvum, P. expansum; producing patulin, P. crustosum; 
producing penitrem A, P. cyclopium or P. aurantiogriseum, P. camembertii; producing cyclopiazonic acid, 
P.  roqueforti, P. camemberti or P. caseicola;  producing penicillin acid, roquefortine, isoflumigaclavines A, 
B, PR toxin, and cyclopiazonic acid (Wawrzyniak and Waskiewicz 2014; Tannous et al. 2014; Bennett and 
Klich 2003). 
 
1.1.2 Toxinogenesis: Conditions Favoring Mycotoxin Production 
 
The presence of fungi, the commodity composition, the agronomy practices, the harvest conditions, handling 
and storage practices all affect the ability of molds and fungi to produce mycotoxins (Bryden 2009). 
Moisture and temperature are the two major influences on growth of mold and on production of mycotoxins 
(Pitt and Hocking 2009). Higher moisture levels (20-25%) are usually required by pathogenic fungi that 
attack and spread into crops prior to harvest than for fungi to proliferate during storage (13-18%). In addition 
to moisture and temperature, other factors such as water activity within the interval 0.90-0.995 and at least 
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50% of CO2 being available also affect the reduction of production of ochratoxin A (OTA), and particularly 
inhibit the growth of P. verrucosum and other molds in wheat grain (Battacone et al. 2010). For this reason, 
some mycotoxin contaminations are preferentially driven, prior to harvest (on field contamination) and 
others the optimum conditions cause contamination in storage. As a result most feedstuffs with moisture 
contents above 13% are susceptible to mold growth and mycotoxin formation (Magan 2006). Toxins are 
produced at temperatures ranging from 0°C to 35°C depending on the fungal species (Frisvad 1995). For 
instance, the temperatures for optimum growth and for OTA production by P. verrucosum have been shown 
to be with 15-35°C (Magan and Aldred 2005). In partially dried grain, the key mycotoxigenic molds are P. 
verrucosum (ochratoxin) in damp cool climates of Northern Europe, and A. flavus (aflatoxins), A. ochraceus 
(ochratoxin) and some Fusarium species (fumonisins, trichothecenes) on temperate and tropical cereals 
(Magan and Aldred 2007). Thus, the geographic-repartitioned temperatures indicate that globally there will 
be a differentiation between the fungal species that are active and thus the potential for contamination with 
the toxins they produce. 
 
1.1.3 Mycotoxins in Feed 
 
In general only a few mycotoxins, and in particular five mycotoxins/mycotoxin groups have received 
widespread attention among 300-400 mycotoxins known today (Schatzmayr and Streit 2013; Bennett and 
Klich 2003; Hussein and Brasel 2001). These five mycotoxins/mycotoxin groups and their prevalence as a 
percentage of the 19,757 samples of feed and feed raw material tested (with the average contamination 
expressed as µg/kg feed or feed raw materials) are aflatoxins most often detected in South Asia (78% 
positives; 128 µg/kg), followed by South-East Asia (55%; 61 µg/kg). ZEA was most prevalent in North Asia 
with 56% positive samples containing an average of 386 µg/kg of the mycotoxin. North Asia is also the 
region where the occurrence of DON was highest (78%; 1,060 µg/kg). The highest average DON 
contamination however has been observed in North America, where positive samples (68%) contained an 
average of 1,418 µg/kg DON. Fumonisins were most frequently detected in South American samples (77%; 
2,691 µg/kg). OTA prevalence and average contamination were highest in South Asia (55%; 20 µg/kg). 
Eastern European samples frequently showed positive for OTA as well (49%), but the average contamination 
was much lower at 4 µg/kg feed (Schatzmayr and Streit 2013; Streit et al. 2013; Rodrigues and Naehrer 
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2012). In maize, peanuts, cotton seed, rice and spices, significant levels and types of aflatoxin can be found 
in the various countries in the world, and that producing aflatoxigenic species (Reddy et al. 2010). 
Ochratoxin contamination can occur in wheat, barley, rye and grapes (Jørgensen 2005). In many situations, 
especially pre-harvest, the fungi that produce these toxins also produce other toxins and co-contamination 
may occur (Glenn 2007) as 38% of 17,316 samples analyzed contained two or more mycotoxins, suggesting 
that co-contamination is frequently observed in finished feed sample (Streit et al. 2013; Schatzmayr and 
Streit 2013). A global survey of the incidence of mycotoxins (aflatoxin B1 (AFB1), DON, fumonisins B1 
(FB1), B2 (FB2) and B3 (FB3), OTA, T-2 toxin and ZEA) in animal feedstuffs showed significant regional 
differences at low level of contamination, particularly between tropical and temperate areas (Rodrigues and 
Naehrer 2011; Rodrigues and Griessler 2010). 
 
Apart from those mentioned mycotoxins, orther mycotoxins or toxic metabolites have been reported such as 
ergot alkaloids, citrinin, patulin or its metabolites (clavacin, claviformin, expansin, mycoin c and penicidin), 
DON metabolites (DOM-1, 3-epi-DON, DON-3-glucoside, 3-acetyl-DON, 15-acetyl-DON, etc.), 
moniliformin, phomopsins, tremorgenic mycotoxins, glutinosin (a mixture of the macrocyclic trichothecenes 
verrucarin A and B), penicillin acid, roquefortine, isoflumigaclavines A and B, PR toxin, penitrems, 
janthitrems, lolitrems, aflatrem, paxilline, paspaline, paspalicine, paspalinine, paspalitrem A and B, 
cyclopiazonic acid, citreoviridin, luteoskyrin, rugulosin, rubroskyrin, etc. (Milićević et al. 2010; Bennett and 
Klich 2003). 
 
1.2 Mycotoxin Contamination of Feedstuffs 
 
Many factors (Figure 1-2) contribute to feed contamination and subsequent animal exposure (Bryden 2012). 
Two mains factors are genetic modification of crops to resist fungal attack and feed handling on farm. 
Mycotoxins can occur in the food chain in the field or/and during storage, and their occurrence increases 
when shipping, handling, and storage practices permitting mold growth (Reddy et al. 2010). Incorrect bulk 
handling and inferior storage conditions, such as prolonged time in storage and low dry matter content 
(below 87%), influence contamination of feedstuffs. The on-farm occurrence of ZEA, DON and aflatoxin in 
forage, cereal grains and straw was investigated in Australia and the mycotoxins were found in all the 
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commodities, and highest occurrence being ZEA (Moore et al. 2008). Recent study raised concerns the 
excessive aflatoxin levels in maize from Bulgaria, Romania and Serbia (Schatzmayr and Streit 2013). In the 
survey, the lowest frequency of contamination was found in grains whereas grains are often considered the 
only source of mycotoxins when examining a field toxicosis. These results pointed out the potential risk of 
contamination of feedstuffs and forages rather than grain used in animal production. In addition, the 
contamination of straw, which may be used as a roughage source in ruminant and horse diets or as bedding 
for horse, poultry and pigs, may also be a source of mycotoxin exposure on farm (Katie 2013; Degen 2011).  
[Insert Figure 1-2 here] 
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Figure 1-2. Factors affecting mycotoxins occurrence in feed/food 
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2. Mycotoxins and Pathologies 
 
The pathologies induced by mycotoxins and the field cases will be described in livestock excluding pets, 
whilst noting  the sensitivity of the pets to some mycotoxins i.e. dogs and cats to Aflatoxin and dogs to OTA 
(Bryden 2012). 
 
2.1 Mycotoxins and Livestock Diseases 
 
Livestock may be accidentally fed with contaminated feed resulting in animal disease or health problem 
because of the toxic effect of the mycotoxins. The susceptibility of species like pigs, poultry or ruminants to 
mycotoxins is different (Steyn et al. 2009), and these differential sensitivities might be due to the difference 
in absorption, metabolism, distribution, and elimination of the mycotoxins (Petska 2007).  Presented below 
are the toxic effects of the five mycotoxins or mycotoxin groups that are considered to be most frequently 
occurring and worldwide the most significant ones (Schatzmayr and Streit 2013; Bryden 2012). 
 
2.1.1 Aflatoxins 
 
Three species of Aspergillus including A. flavus, A. parasiticus, and A. nomius that contaminate plants and 
plant products may produce aflatoxins (Reddy et al. 2010; JECFA 2001) with several chemical forms such as 
aflatoxin B1, B2, G1, G2, M1. AFB1 is the most frequently occurring, leading to AFB1’s metabolite in milk 
from lactating humans and animals that consume AFB1-contaminated food or feed: aflatoxin M1 (Alborzi et 
al. 2006). AFB1 is the most potent known carcinogen inducing hepatocarcinogenicity in both animals and in 
humans (JECFA 2001; IARC 1993). The absorption of aflatoxin is rapid before primary metabolism by liver 
microsomal enzymes to active or detoxified metabolites (Haschek et al. 2002). The reliable biomarkers of 
aflatoxin exposure are blood (aflatoxin-albumin adducts in serum) and urine (aflatoxin N7-guanine adducts) 
(Wild and Turner 2002; JECFA 2001). 
 
In poultry, aflatoxin contaminated feed ingestion is frequently observed as chronic toxicity (Bailly and 
Guerre 2008). Doses of about 0.1 mg/kg, 0.3-0.5 mg/kg and 0.5-2 mg/kg feed in duck, turkey and chicken, 
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respectively, for long exposure of more than 2.5 months resulted in poor growth performances and 
productions, hemorrhage (Dalvi 1986), hepatic lesions, fibrosis and proliferation of biliary ducts (Bailly and 
Guerre 2008). Similar signs have also been observed in ruminants such as reduced feed intake and milk 
production, diarrhea, biochemical changes in serum, hepatitis changes at necropsy such as congestion, 
hemorrhage, enlarged gall bladder and color changes showing cirrhosis and necrosis (Morgavi et al. 2008). 
The decreases of growth rate and feed intake with increasing aflatoxin concentrations in the diet were 
reported in pig (Dersjant-Li et al. 2003). Adult animals are less sensitive to the toxic effect of aflatoxins than 
young animals (Barringer and Doster 2001). For aflatoxins, specific regulations have been set, particularly in 
feed for dairy cattle in a number of EU countries, ranging from 5ppb (the majorities of country) to 50 ppb for 
aflatoxin B1 in animal feed and from 0 or 0.01 ppb to 50 ppb for total aflatoxins (FAO, 2004). 
 
2.1.2 Deoxynivalenol (DON) 
 
DON is the main mycotoxin of the type B trichothecenes, which occurs predominantly in grains such as 
wheat, barley, and maize and less often in oats, rice, rye, sorghum and triticale (Sugita-Konsihi and 
Nakajima 2010). DON is rapidly metabolized (Petska 2007) and de-epoxidation via gut microbiota may be 
extensive i.e. in pigs (Eriksen et al. 2002), cows (Annison and Bryden 1998) and rats, but not in chickens, 
horses and dogs (Swanson et al. 1988). It is suggested that pigs are most sensitive species to DON (Pestka 
2010). The classical clinical signs or response following ingestion of DON are feed refusal and emesis; 
probably due to a neurochemical imbalance in the brain (Pestka and Smolinski 2005). It was reported that 
DON stimulates the main structures involved in feed intake in pigs, and the anorexigenic effects of DON 
could be contributed by catecholaminergic and NUCB2/nesfatin-1 neurons (Gaigé et al. 2013). 
 
Feed intake and body weight were reduced when the piglets were fed the diet contaminated with DON 
2.29mg/kg feed for 4 weeks (Pinton et al. 2012). However, a chronic exposure to low doses of DON did not 
elicit important clinical signs such as body weight gain, hematology and biochemistry in piglets (Grenier et 
al. 2011). Feed refusal, reduced weight gain, and emesis have been observed in pigs while consuming a level 
of DON as low as 1 mg/kg, >2–5 mg/kg and >20 mg/kg feed, respectively (Haschek et al. 2002; Trenholm et 
al. 1984). DON has been found to decrease feed intake in ruminants at the levels of 10-20 mg/kg feed 
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(Osweiler 2000) whereas poultry tolerate up to 20 mg/kg DON in feed (Petska 2007). The resistance to DON 
explained by the detoxification by the intestinal microflora of  DON to DOM-1 (He et al. 1992), poor 
absorption into plasma, rapid elimination in excreta and low-level residues in tissues in chicken (Prelusky et 
al. 1986). Although poultry can tolerate the toxin, in broiler chickens, 10 mg/kg DON in the diet has been 
found to impair nutrient cotransport in the jejunum and appeared to alter the gut function while not affecting 
the growth performance (Awad et al. 2004). 
 
Pestka (2008) reported the lethal DON doses that affect histopathology range from hemorrhage or necrosis of 
the intestinal tract, necrosis in lymphoid tissues and bone marrow, to kidney and heart lesions. The clinical 
signs of ingestion of DON include gastrointestinal disorders, diarrhea, (Haschek et al. 2002) alteration in 
immune function (Bondy and Pestka 2000) and predisposition to infections by enteric pathogens (Bracarense 
et al. 2011). A lethal dose (LD50) for DON at 27 mg/kg body weight (subcutaneously) and 140 mg/kg body 
weight (orally) have been reported in 10-day old duckling and 1-day-old broiler chicks, respectively whereas 
acute exposure to relatively low doses at ≥50µg/kg body weight (intraperitoneally or orally) can cause 
vomiting in pigs. However, no lethal doses have been suggested in ruminants because of their rumen 
microflora metabolism which plays a significant role in DON detoxification (Petska 2008; Pestka 2007). 
Furthermore, mild renal nephrosis, reduced thyroid size, gastric mucosal hyperplasia, increased 
albumin/alpha-globulin ratio, and sometimes mild changes in other hematological parameters in pigs have 
also been reported due to the effects of DON (JECFA 2001). Taken together, DON is not considered to be 
acutely toxic to farm animals, and the concern is economic losses due to poor performance (Morgavi and 
Riley 2007). 
 
2.1.3 Fumonisins 
 
It has been shown that fumonisins at high doses cause porcine pulmonary edema and equine 
leukoencephalomalacia (Haschek et al. 2002). Porcine pulmonary edema syndrome is characterized by 
dyspnea, weakness, cyanosis and death. The reproduction and performance disturbance are not frequently 
observed (Taranus et al. 2008). Different states of interstitial and interlobular edema with pulmonary edema 
and hydrothorax at varying amounts of clear yellow fluid accumulate in the pleural cavity have been seen in 
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pig necropsy affected by fumonisins (WHO 2000). Fumonisins disrupt sphingolipid metabolism by 
inhibiting ceramide, an enzyme responsible for the acylation of sphinganine and sphingosine (Steyn et al. 
2009). Available biomarkers of exposure to toxic levels of fumonisins in farm animals can be used through 
plasma, ratio of sphinganine/sphingosine in serum or urine (Voss et al. 2007) and the increase in serum and 
tissue of free sphingoid bases (Riley et al. 1994). 
 
Equine leukoencephalomalacia is characterized by lethargy, head pressing and reduced feed intake, followed 
by convulsions and death after several days (Morgavi and Riley 2007), and the presence of liquefactive 
necrotic lesions in the cerebrum white matter, however, the grey matter may also be involved (WHO 2000). 
In addition, abnormalities of histology in kidney and liver such as apoptosis and cell regeneration have also 
been found in horses and ponies, following minimum toxic doses of FB1 between 15 ppm and 22 ppm in 
feed, but not below 6 ppm (JECFA 2001). It has been reported, besides liver and lung, that fumonisins target 
pulmonary intravascular macrophages, kidney, pancreas, oesophagus and heart (Morgavi and Riley 2007; 
WHO 2000). In poultry, diarrhea, increased liver weight and growth retardation have been reported when 
consuming the fumonisins-contaminated feed. In feed, pure FB1 at 10 ppm and fumonisins B1 at 30 ppm 
from F. verticillioides culture material have altered haematological parameters in broiler chicks (Morgavi 
and Riley 2007; JECFA 2001). 
 
2.1.4 Ochratoxins 
 
The kidney is the target organ of ochratoxins, particularly OTA that induces nephropathy (Marquardt and 
Frohlich 1992). Ochratoxin has been detected in blood, milk including human, pork and other animal tissues 
(Reddy et al. 2010). Ruminants are insensitive to OTA, because they largely convert OTA into ochratoxin α 
in the rumen (Jouany and Diaz 2005; Galtier and Alvinerie 1976) and OTA naturally occurring in feed is not 
regarded as a health threat. It is highly toxic, however, in monogastric farm animals for instance poultry and 
pigs. High doses of 20 mg/kg can reduce feed intake or cause death with friable livers and pulmonary edema 
in sheep and in lambs respectively (Morgavi et al. 2008). 
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Feed contaminated by ochratoxins caused poultry disease (Hamilton et al. 1982) and endemic disease in 
Denmark (Krogh 1987). In poultry, the concentration of OTA at 0.3-4 mg/kg feed for several weeks and at 2-
10 mg/kg once was reported to induce chronic and acute toxicity, respectively with decreased growth rate, 
poor feed conversion ratio, low egg production, moist feces, degeneration and focal necrosis of liver (Bailly 
and Guerre 2008). Significant toxic effects have been shown in chicken fed a diet of about 4 mg/kg for 
degeneration of internal organs such as kidney, liver, lymphoid, changes of biochemical parameters, and also 
immunosuppression (Stoev 2008).  
 
Ochratoxin showed a mild effect on microscopic lesions in 3-4 month pigs with level of about 200 µg/kg 
feed and 90 µg/kg feed in combination with penicillic acid, and a macroscopic kidney damage with 180 
µg/kg feed in combination with penicillic acid. These results suggested that interaction effects of ochratoxin 
with other mycotoxins are very important to studied (Stoev 2008). Battacone et al. (2010) reported reduced 
feed intake and altered metabolism in pigs exposed to OTA, with several changes of serum blood parameters 
such as hyperproteinemia and azotemia, hypocholesterolemia and hypercalcemia. 
 
Toxicological studies from animals lead to European Union Scientific Committee to postulate a limit level of 
OTA intake below 5 ng/kg of body weight per day (Sweeney et al. 2000). However the EFSA revised this to 
17 ng/kg of body weight per day due to its indirect effect on genotoxicity (EFSA 2006), and this revision has 
been currently applied (EFSA 2010). 
 
2.1.5 Zearalenone (ZEA) 
 
McErlean (1952) was the first to suggest that Fusarium graminearium caused probably hyperoestrogenism in 
pigs (Bryden 2012). Farm animals, particularly pigs, a very sensitive species, are reported to be affected by 
ZEA acting by hyperrestrogenism at prepuberty (Gremmels and Malekinejad 2007; Osweiler 2000) and 
inducing vulvovaginitis and anestrus (Raisbeck et al. 1991). Dietary levels of ZEA 1-5 ppm and 3-10 ppm 
can induce vulvovaginitus and anestrus respectively while other clinical signs have been observed in 
ovariectomized sows, such as tenesmus. Vaginal and rectal prolapse, reduced litter size, fetal resorption, 
implantation failure, reduced libido and reduced plasma testosterone have been seen in young female pigs 
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(Osweiler 1986; Weaver et al. 1986). Alpha-zearalenol and β-zearalenol are major metabolites resulting from 
the interaction of ZEA with estrogen receptors. The metabolites elicit estrogenic activity in animals, 
particularly pigs, which correspond to their binding affinities for mammary, uteri and hypothalamic 
oestrogen receptors (Fink-Gremmels and Malekinejad 2007; Zinedine et al. 2007). ZEA is reported in the 
field outbreaks of estrogenic syndrome in pigs in Europe, Africa, North America, Africa, Australia and Asia 
(Christensen 1979), and suspected to cause reproductive problems in grazing sheep (CAST 2003), ruminants 
(Raisbeck et al. 1991). It was reported to disturb an induction of parturition program together with signs of 
estrogenism in newborn piglets (Alexopoulos 2001). However, cattle (Weaver et al. 1986), cycling mares 
(Juhasz et al. 2001) and poultry (Haschek et al. 2002) have been reported more resistant to the estrogenic 
effects of ZEA at low doses similar to the natural contamination. 
  
2.2 Diagnoses of Mycotoxicosis 
 
In cases where animal productivity is reduced or in cases of disease, a mycotoxicosis may be suspected when 
outbreaks exhibit the following characteristics: the cause is not readily identifiable; the condition is not 
transmissible; syndromes may be associated with certain batches of feed; treatment with antibiotics or other 
drugs has little effect; and outbreaks may be seasonal as weather conditions may affect mold growth (Bryden 
2012). 
 
To ascertain that a mycotoxin is the underlying cause of a field problem it is necessary to demonstrate 
biologically effective concentrations of the toxin in the suspect feed. This needs a homogenous feed sample 
representative (Whitaker 2006). In making a diagnosis, not only mycotoxins must be considered for their 
unique effects, but also they must be evaluated for possible interactions with infectious agents and 
environmental stressors commonly encountered in animal production (Hamilton 1978). As animals may be 
fed with diets that contain low levels of more than one toxin, then field situations are often more 
complicated. For instant, aflatoxins, DON, ZEA and fumonisins can occur together in the same grain (CAST 
2003). Moreover, many fungi simultaneously produce several mycotoxins, especially Fusarium species. 
Toxicity resulting from the interaction between mycotoxins is usually additive and not synergistic as often 
suggested (CAST 2003). Thuvander et al. (1999) found that combination of NIV with T-2 toxin, DAS or 
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DON resulted in an additive effect. In addition, recent results in Caco-2 cells model showed that interaction 
between DON and NIV were synergistic at in vitro cell level (Alassane-Kpembi et al. 2013) and less than 
additive at ex vivo explant level (Kolf-Clauw’s personal communication). Besides, mycotoxin interaction is 
complex which varies according to the animal species, the toxin doses, the exposure duration as well as the 
end points measured (Grenier and Oswald 2011). 
 
In any situation, keeping aware of the possible consequences of mycotoxin-contaminated feed when animal 
productivity is identified as being poor or simply unexplainable and the condition cannot be diagnosed as 
being caused by pathogenic agents. 
 
2.3 Field cases 
 
A disease outbreak in the field suspected to a specific mycotoxin in feedstuff can be very difficult to define 
since the signs of disease are generally subtle and unspecific (Morgavi and Riley 2007), and they usually do 
not cause acute disease. In the case of acute diseases, multiple interacting factors can modify the expression 
of toxicity (Hamilton et al. 1982). However, the incidence of acute disease, not associated with known 
infectious diseases and often involving mortality or evidence of acute toxicity, in farm animals indicated the 
presence of mycotoxins in feeds (Morgavi and Riley 2007). 
 
Long before these toxins were discovered, aflatoxin, DON, ergot, fumonisins and ZEA, mold-contaminated 
feed was assumed to be the cause of animal disease in field outbreaks (Morgavi and Riley 2007). Feed 
contaminated with aflatoxin (corn and peanut meal) killed 12 yearling colts, 2-year-old horses, and a 7-year-
old mare in Thailand and the southern USA, respectively. The similar autopsy and hematological and serum 
biochemical changes were found suggesting that horses are susceptible to aflatoxicosis (Smith and Girish 
2008). In pigs, cases of pulmonary edema were reported during 1989 in the US. It was concluded that this 
was due to consumption of corn contaminated with Fusarium verticilloides, a fumonisins-produced fungus, 
ranging in levels from 20-360 mg/kg feed. This syndrome was experimentally reproduced in 3 of 4 piglets 
treated with FB1 at 10mg/kg feed, that were observed to have a slight pulmonary edema (Taranu et al. 2008). 
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Another study in pigs fed Fusarium culture material reported evidence of pulmonary edema was detected at 
a concentration of FB1 equivalent to 0.4 mg/kg body weight per day (JECFA 2001). 
 
Fumonisins-caused equine leukoencephalomalacia has been reported in corn contaminated with fumonisins, 
and the fatal equine leukoencephalomalacia has been reproduced with a contamination of 10mg/kg feed. 
Fumonisins B1 at the level of greater than 10mg/kg often encounter the field outbreak of equine 
leukoencephalomalacia since 1983 in many regions of the US including Indiana, and Southern Brazil (Smith 
and Girish 2008). Thus, 66 purebred Arabian horses in Arizona fed with the diet containing FB1 37-122 
mg/kg showed the clinical feature such as hemorrhagic foci of the brain stem, liquefactive necrosis of 
cerebral white matter, histopathological changes including rarefied white matter with pyknotic nuclei and 
eosinophilic (Smith and Girish 2008). The other cases of equine leukoencephalomalacia outbreaks have also 
been reported in South Africa suspectedly caused by consumption of moldy maize, and the clinical signs 
were blindness and ataxia (Pienaar et al. 1981). 
 
Mycotoxicosis from Stachybotrys (atra), a saprophytic mold, was first reported in deer in Western Europe in 
1977 and has been reported as frequent causes that lead to the death of horses, particularly in the Southern 
parts of France (Le Bars and Le Bars 1996). In Morocco in 1991, approximately 800 donkeys, mules and 
horses died from Stachybotryotoxicosis. In any cases of death, moldy straw was suspected. The symptoms of 
this mycotoxicosis ranging from mild cases: hyperesthesia (jump refusal in race horse), rhinitis, 
conjunctivitis to severe cases: oral mucosa necrosis, bleeding (from small injuries), tissue hemorrhage (Le 
Bars and Le Bars 1996). Spontaneous porcine and avian nephropathy were frequently observed. The relative 
concentrations ranged from 91 to 310 ppm of OTA in feed samples in Bulgaria where the nephropathy 
occurrences in different batches of slaughtered pigs/chicks varied from 1-2% up to 90-100% (Stoev 2008). 
 
Field outbreaks of porcine hyperestrogenism (vulvo-vaginitis) characterized by swelling and reddening of 
the vulva and teats in prepubertal gilts reported in South Africa, were caused by the ingestion of Fusarium 
graminearum infected maize contaminated with ZEA 10 mg/kg feed (Aucock et al. 1980). 
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In farm animal disease outbreaks, DON and other trichothecenes (including T-2 toxin and DAS) have been 
implicated in many areas of the world, and in pigs, cattle and chickens, the most commonly observed effect 
is feed refusal (Morgavi and Riley 2007; Haschek et al. 2002; Osweiler 2000). In suspected field outbreaks 
of DON in farm animals or human, β-glucuronidase is a useful urinary biomarker since it hydrolyzes DON-
glucuronide to DON (Meky et al. 2003). 
 
3. Mycotoxins and Animal Productivities 
 
The most difficult consequence after mycotoxin contamination of animal feed supply chain is the reduction 
of the animal productivity, but not acute disease episodes (Bryden 2012). The poor growth performance of 
animal which is not due to the nutritional content in feed, sometimes related to a low dose ingestion of toxin 
which resulted in metabolic disturbances and/or may be accompanied by pathological change (Haschek et al. 
2002). The effects of mycotoxins may considerably vary according to the type of mycotoxins involved and 
the animal species. Pig is considered as the most sensitive species to DON toxic effects followed by rodent > 
dog > cat > poultry > ruminants (Pestka and Smolinski 2005). Pig has been shown to be also the most 
sensitive species to other mycotoxins, like NIV (EFSA 2013), ZEA (Fink-Gremmels 2008), fumonisins 
(Morgavi and Riley 2007) whereas horses are also the species most sensitive to fumonisins (Smith and 
Girish 2008). An overview of the animal performances affected by mycotoxins, particularly pig and poultry 
(ruminants are more resistant) have highlighted that the effects of trichothecenes on feed intake may be 
influenced by factors such as age, body weight, sex, feeding period, feeding system and diet, specifically in 
pigs (Eriksen 2003). Furthermore, the genetic heterogeneity of these species may often lead to large 
individual differences and inconsistent results comparing to rodents. 
 
3.1 Feed Intake 
 
Growth retardation, commonly induced after repeated ingestion of a contaminated feed (chronic 
mycotoxicosis), is usually the first sign. However, Hedman et al. (1997a) study on NIV in young male pigs 
(pathogen-free Swedish Landrace x Yorkshire) exposed to 2.5 or 5 mg purified NIV/kg feed in the diet for 3 
weeks revealed no sign of altered feed intake or body weight and no vomiting or clinical problem. Feed 
 35 
intake was found to be reduced in pig fed a diet containing 5.8mg NIV/kg feed or more but not in pigs fed 
2.9 mg NIV/kg feed. In animal studies, DON (in pigs) and ergot alkaloids (in chickens) are the mycotoxins 
most often involved in feed refusal, which probably involve neurochemical mechanisms (Brake et al. 2000; 
Bakau et al. 1998). It has also been demonstrated that chronic dietary exposure to DON causes impaired 
weight gain, anorexia, decreased nutritional efficiency and immune dysregulation (Haschek et al. 2002; 
Trenholm et al. 1984). Moreover, it is estimated that the diet contaminated with low level of aflatoxin, 
fumonisins and DON, depressed the growth rate and feed intake. For instance in the diet, each increasing 
mg/kg (0.2-4mg/kg) of aflatoxin leads to 16% depressed in pigs and 5% in broilers; and DON (1-20mg/kg 
feed) leads to 8% depressed marginal growth rate reduction (MGR) in pigs while broilers showed no 
response to DON concentrations below 16 mg/kg feed. In the same consequence, fumonisin impacted less on 
the growth rate that was estimated to be at 0.4% and 0%/mg per kg for pigs and broilers, respectively 
(Battacone et al. 2010; Dersjant-Li et al. 2003). 
 
3.2 Animal Reproduction 
 
Mycotoxin ingestion may affect reproductive efficiency of both males and females with impairment of 
metabolic function (Diekman and Green 1992). ZEA may increase abortion, stillbirths and neonatal mortality 
in pregnant gilts and sows. These two stages of swine, gilt and sow, particularly the prepubertal gilts are the 
most sensitive ones (Kanora and Maes 2009). ZEA at 22 mg/kg diet cause alterations in the reproductive 
tract of swine such as in the uterus, and affects follicular and embryo development (Tiemann and Dänicke 
2007). Litter size may be decreased by ergot alkaloids (Kanora and Maes 2009; Bryden 1994). 
 
3.3 Animal Immunomodulation 
 
It is pointed out that mycotoxins are immunomodulators, mostly immunosuppressive (Richard 2008) and are 
known to increase the susceptibility of animals to infectious disease (CAST 2003). Pestka et al. (2004) 
showed that dose frequency and duration of exposure to DON will determine whether it has an 
immunostimulatory or immunosuppressant effect including apoptosis and differential gene expression in 
immune cells. The experimental result in pig showed that DON could be immunotoxic with a lowest-
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observed-adverse effect level of 0.12 mg/kg body weight per day (Petska 2010) or chronic exposure to low 
doses of DON or FB especially in the combination (Grenier et al. 2011; Pinton et al. 2008). NIV has also 
been observed to adversely affect immune system by decreasing the cellularity of the spleen in animals 
exposed to 5 mg NIV/kg feed (Hedman et al. 1997b). Negative effect of OTA has been reported consisting in 
severe immunosuppression in laying hens fed a diet contaminated at 1mg/kg of feed for 60 days (Battacone 
et al. 2010). 
 
Ingestion of toxins can reduce the effectiveness of vaccination programmes and this failure during 
aflatoxicosis is related to the immunotoxicity. The toxin impairs the immune function by decreasing cell-
mediated immunity and by inducing an inflammatory response (Meissonnier et al. 2008; Oswald et al. 2005). 
Bracarense et al. (2011) postulated that the chronic ingestion of low dose of mycotoxins alters the intestine 
(induces tissue lesions, modulate the immune cell count as well as the cytokine synthesis and decreases the 
expression of proteins involved in cell adhesion) and thus may predispose animals to infections by enteric 
pathogens. In agreement to that, studies in pigs have revealed that fumonisins have increased susceptibility to 
intestinal infection with Escherichia coli (Oswald et al. 2003). 
 
3.4 Economic Impacts of Mycotoxin 
 
The economic effects of mycotoxin contamination are profound, and crops with large amounts of 
mycotoxins often have to be destroyed or diverted into animal feed resulting in reduced growth rates, illness, 
and death (Reddy et al. 2010). Iheshiulor et al. (2011) suggested that there are multiple criteria for assessing 
the economic impact of mycotoxins on animal agriculture and human including loss of animal life, livestock 
production and forage crops and increased cost of health care, veterinary care regular costs and research 
costs focusing on relieving the impact and severity of the mycotoxin problems. Moreover, the impact can be 
on feed safety as well as security. 
 
3.4.1 Feed Securities 
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Between humans and animals and at the same time with the world population growing, competition is 
increased for food commodities as developing countries raise their appetite for animal products (Woodward 
2010). The threat from fungal invasion of crops is also likely to increase due to the climate change (Garrett et 
al. 2006). In consequence, fungal infection of crops can also be facilitated by the change in insect population 
dynamics due to the climate change (Wu et al. 2011). It is obvious that mycotoxins remain a threat to global 
food supplies as a product of plant disease (Strange and Scott 2005) and the degree of risk depends on the 
country or region in which crops are grown. These concerns are due to the biological complexity involving 
predicting changes in ambient temperature, relative humidity, carbon dioxide levels, interrelationships 
between different fungal genera and different crops in different geographical locations (Bryden 2012). 
 
3.4.2 Tissue Residues 
 
Animals consuming mycotoxin-contaminated feeds can produce meat and milk that contains potentially 
toxic residues (Reddy et al. 2010). Contamination of animal products with mycotoxins or their metabolic 
products has been a crucial issue and poses problems in public health (Boudergue et al. 2009). There is no 
evidence for tissue accumulation of DON (Eriksen et al. 2003; JECFA 2001) and its transfer into milk 
(Keese et al. 2008) due to its rapid metabolism and de-epoxidation via gut microbiota (Eriksen et al. 2002). 
However, aflatoxin residues are most likely contained in milk, especially the hydroxylated metabolite of 
AFB1, aflatoxin M1 in milk representing from 1 to 6% of dietary intake of aflatoxins (Fink-Gremmels 
2008). In several European countries, OTA has been found in kidneys, blood, muscle tissues and liver of the 
pigs (Van Egmond and Speijers 1994). Petterrson (2004) showed the half-life of OTA in chickens and pigs 
as being of 140-180 h and approximately 4 h, respectively. However the tissue deposition of toxins, for 
instance OTA, is different between poultry and pig due to their pharmacokinetics (Petterrson 2004). 
Consumption of pork has been a significant source of human exposure to OTA (Jørgensen and Petersen 
2002) and the presence of this mycotoxin in animal-derived products (Gareis and Scheuer 2000). 
 
Not all residues of mycotoxins such as trichothecenes, fumonisins and ZEA are a threat to public health. 
Experimental animals were fed with very high levels of the toxins, and very low levels were actually found 
in the animal tissues (Petterrson 2004; Pestka 1995). Fumonisins are able to disrupt sphingolipid metabolism 
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(Steyn et al. 2009), and as the result, sphinganine accumulation in tissues initiates a cascade of events that 
may cause toxicity, especially of the liver and kidneys, and carcinogenicity (Voss et al. 2007). When 
extrapolating or predicting tissue residues, caution should be made as there are often insufficient data on 
which to anticipate the outcome of any field toxicosis (Pestka 1995). 
 
4. Strategies for Prevention and Management 
 
Reducing the concentration of mycotoxins in feed or a given crop is possible with the preventive methods. 
However, concentrations exceeding the limit prescribed in regulations may still occur in spite of all efforts 
(Schatzmayr and Streit 2013). Because of the stability of these compounds, reduction is a difficult task (Cole 
1986). Therefore, it is important to limit the mycotoxin contamination of food and feed materials prior to 
harvest. The best approach is minimizing mycotoxin production itself by harvesting the grain at maturity and 
low moisture and then storing it at cool and dry conditions. This is difficult to achieve during a wet season 
harvest or in countries with a warm and humid climate (Huwig et al. 2001). Prevention and reduction of the 
occurrence and the impact of mycotoxins requires an integrated understanding of crop biology, agronomy, 
fungal ecology, harvesting methods, storage conditions, feed processing and detoxification strategies 
(Schatzmayr and Streit 2013; Bryden 2009). Prevention involves first reduction of mycotoxin levels in 
feed/foodstuffs and then further increasing the intake of diet components through supplementation such as 
vitamins, antioxidants, suphur-containing amino acids, trace elements and substances that are known to 
prevent carcinogenesis (Creppy 2002; Nahm 1995). 
 
However, no single treatment in degrading or removing toxins and retaining the nutritional and functional 
qualities of the treated commodity has proved completely successful since grains may be naturally 
contaminated with multi-mycotoxins and their distinct chemical characteristics (Bryden 2012; Park and Price 
2001). 
 
4.1 Agricultural Practices 
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Good agricultural practice such as crop rotation and tillage, ploughing after wheat and maize, reducing plant 
density and adequate irrigation, can all minimize the likelihood of mycotoxin formation (Schatzmayr and 
Streit 2013). For example, DON level was low (from 15.1ppm to 1.2ppm) in the wheat crop following maize 
as a result of one year rotation between crops (Jouany 2007; Schaafsma et al. 2001). Plant protection 
products such as microbial antagonists are a promising alternative to conventional fungicides and are also 
regarded as biological control. For example Bacillus subtilis strains have been reported to inhibit the growth 
of fusaria (Jouany 2007) and atoxigenic A. flavus strains successfully reduce aflatoxin contamination in 
treated crops (Cole and Cotty 1990). Genetic modification of fungi and crops is considered as the best 
solution. For example, quantitative trait loci for Fusarium resistance have been identified in wheat, and often 
coincide with genes controlling morphological plant characteristics (Miedaner et al. 2006). However, other 
varietal characteristics that do not seem to relate to fungal resistance may also have an impact on mycotoxin 
levels (Anderson 2007). 
 
4.2 Feed Storage and Processing 
 
Grains have to be dry to minimize mycotoxin production. Whilst grain may go into storage at a uniform 
temperature, over a period the grain mass will cool at different rates in the center compared to the periphery. 
Storage of grain at an appropriate moisture content, generally below 13% moisture, regular inspection of 
grain for temperature, wet spots and insect infestation will limit the potential for fungal development in feeds 
and feedstuffs. The rapid turnover of feed in high volume animal units will also reduce the risk of feed 
contamination, because there will be less time for fungi to grow and to produce toxins (Magan et al. 2010). 
Good and Hamilton (1981) demonstrated that poultry performance can be improved significantly by 
increasing feed turnover or decreasing feed residence time on farm simply by reducing the amount of feed 
per delivery. Thirty five years later it is still good practice to match feed deliveries and storage time to usage 
to minimize residence period. 
 
Animal feed pelleting, milling or processing affect mycotoxin levels in finished feed. It is reported that most 
mycotoxins are heat-resistant within the range of common food processing temperatures (80-121 °C), so 
little or no reduction in overall toxin levels occurs as a result of normal cooking conditions such as frying 
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and boiling (Kabak 2009). However, AFB1 and AFB2 levels can be reduced by cooking and/or processing of 
feed up to 41% of their initial levels (Furtado et al. 1981). Processing time and temperature affect the 
decomposition rate of fumonisins B1 and B2 which start at 150 to 175 °C. It is known that 90% of 
contamination was them were lost after 60 min treatment (Jackson et al. 1996). DON and ZEA are reported 
as being stable compounds and not known to be destroyed by thermal processing (Visconti et al. 2004; 
Gajecki 2002). Over 50% of OTA in wheat was decomposed at 100°C after 120 min (Boudra et al. 1995). 
DON, NIV, ZEA and fumonisins have been shown almost free from wet milling starch of maize and at the 
same time DON and NIV are recovered in steep water whereas fumonisins and ZEA are found mainly in the 
gluten fraction (Meister and Springer 2004).  
 
The risk of mycotoxin feed contamination would be minimized by ensuring moisture control and 
undertaking regular monitoring and where necessary turning of feed materials. It is also important to note 
that the amount of reduction of mycotoxins relies heavily on the methods of processing e.g. cooking 
conditions, such as temperature, time, water and pH, as well as the type of mycotoxins and their 
concentration in the food or feedstuff. 
 
4.3 Decontamination 
 
Pre- and post-harvest technologies have been investigated to avoid or minimize mycotoxicosis. These are 
physical methods, chemical methods and detoxifying agents (Jouany 2007; Kabak et al. 2006; CAST 2003; 
Ramos and Hernandez 1997; Park 1993). 
  
4.3.1 Physical Methods 
 
Physically, DON, ZEA, fumonisins and aflatoxins in grains can be reduced by implementing washing 
procedures using water and sodium carbonate solution or saturated sodium chloride solution. The DON level 
could be reduced by 65-69% in barley and maize wash (Kabak et al. 2006) while a 54% reduction of patulin 
was observed in apple during washing and handling stages (Acar et al. 1998). A 66% reduction of OTA has 
also been reported in hard wheat containing 618µg/kg toxin by using standard milling techniques (Kabak et 
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al. 2006). Cleaning the kernel surface, thus removing the more heavily contaminated particulate matter, have 
been proved effective in reducing mycotoxin concentrations when there is light to medium contamination of 
the feed. However, this depends on the level of fungal penetration of the endosperm (Kabak et al. 2006). In 
many situations once maize is contaminated with fumonisins, removing the screenings will also remove the 
greatest portion of the grain (Bryden 2012). A simple and the most widely used method for improving 
animal performance is the dilution of mycotoxin-contaminated grain with uncontaminated grain by physical 
mixing (Bryden 2012).This practice is not allowed in some countries e.g. Europe. 
 
4.3.2 Chemical Methods 
 
Chemically, the reduction of aflatoxin levels in feed by ammoniation detoxification is an approved procedure 
for the detoxication of aflatoxin-contaminated feed in some US States as well as in Senegal, France, and the 
UK (Park and Price 2001). It can be also applied to fumonisin concentrations in maize (Norred et al. 1991). 
Calcium hydroxide monoethylamine, ammonia and ozone can destroy some mycotoxins (Huwig et al. 2001; 
Lemke et al. 1999; McKenzie et al. 1997; Park 1993). Nevertheless, the ineffectiveness of these agents 
against other mycotoxins and the possible deterioration of the animal health by excessive residual ammonia 
being present in the feed are the main disadvantages of using this detoxicant. Feed additives like 
antioxidants, sulphur-containing amino acids, vitamins, and trace elements can also be useful as detoxicants 
(Nahm 1995). 
 
4.4 Mycotoxin-Detoxified Agents 
 
Mycotoxin-detoxified agents are assumed to detoxify the contaminated feedstuffs during passage through the 
digestive tract by adsorbing and/or degrading the mycotoxins (Döll and Dänicke 2004). However, their 
efficacy is determined by the chemical structure of both the detoxifying agent and the mycotoxin 
(Avantaggiato et al. 2005). Besides, the effect of specific mycotoxins and detoxifying agents differ for each 
type of animal species. Therefore, the evaluation of the efficacy of detoxifying agents against the different 
mycotoxins presents in feeds is undertaken separately for poultry, swine, ruminants, rodents and other 
species (Boudergue et al. 2009). 
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Furthermore, potential mycotoxin-binding agents such as bleaching clays, synthetic cation or anion exchange 
zeolites, bentonite, lucerne, spent canola oil and hydrated sodium calcium aluminosilicate (HSCAS) have 
been investigated to reduce toxicity in poultry and livestock (Oguz 2011; Jouany 2007; Huwig et al. 2001). 
Phillips et al. (2002) reported that HSCAS is a high affinity adsorbent for aflatoxins, capable of forming a 
very stable complex with the toxin and hence reducing its bioavailability, but is less effective with other 
mycotoxins. 
 
4.4.1 Binders 
 
The efficiency of mycotoxin binders differs considerably depending primarily on the chemical structure of 
both the adsorbent and the toxin (Huwig et al. 2001). A yeast cell wall derived glucomann prepared from 
Saccharomyces cerevisiae has been shown in vitro to efficiently adsorb aflatoxin, ZEA and fumonisins 
(Jouany 2007). The cell wall harboring proteins, lipids and polysaccharides exhibits numerous different and 
easily accessible adsorption centers and different mechanisms such as hydrogen bonds, ionic or hydrophobic 
interaction. It has been suggested that on one gram of cell wall it is possible to bind 2.7 mg ZEA (Huwig et 
al. 2001). Different adsorbents added to mycotoxin-contaminated diets provide hope of being effective in the 
gastro-intestinal tract in a prophylactic rather than in a therapeutic manner. This would make them good 
candidates as feed additives. Natural clay products and synthetic polymers are used as inorganic-mycotoxin-
adsorbing agents. Sodium bentonite has been reported to adsorb AFB1 and FB, while zeolites affect OTA, 
NIV, DAS, T-2 toxin, ZEA and AFB1 (Boudergue et al. 2009). At the same time, activated charcoal which is 
formed by pyrolysis of organic materials is reported to adsorb aflatoxins, fumonisins, OTA and 
trichothecenes (Huwig et al. 2001); while activated carbon showed relevant ability in binding DON and NIV 
(Avantaggiato et al. 2005). Bentonites, zeolites and aluminosilicates are the most common feed additives that 
are effective in binding aflatoxins. Furthermore, cholestyramine was proven to be an effective binder for 
fumonisins (in vivo) and ZEA using an in vitro-dynamic gastrointestinal model (Avantaggiato et al. 2005). 
The utilization of mycotoxin-binding adsorbents is the most applied way of protecting animals against the 
harmful effects of decontaminated feed (Ramos et al. 1996). 
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4.4.2 Biotransforming Agents 
 
Isolating microorganisms and/or enzymes that will degrade or metabolize a mycotoxin rendering it nontoxic 
takes considerable effort (Schatzmayr et al. 2006). For instance, trichothecenes can be detoxified by 
stabilized bacterium (Eubacterium: BBSH 797 and LS100 are two potential microorganisms), i.e. a feed 
additive that removes the epoxide group in vivo (Boudergue et al. 2009; Fuchs et al. 2002) and as such are 
regarded as an approach to mycotoxin decontamination (Molnar et al. 2004). It has been reported that 
interesting results were obtained by applying Flavobacterium aurantiacum NRRL B-184, the soil bacterium, 
to significantly remove aflatoxins from several substrates, including animal feeds, and it was found safe for 
use with chicks (Boudergue et al. 2009). The mixture of aflatoxin-contaminated substance and 
Flavobacterium aurantiacum were incubated at 28°C for 12 hours and it was observed that all of the 
aflatoxin G was removed, as well as a part of aflatoxin B, which was diminished. Moreover, the strain 
Nocardia asteroids reduced AFB1 by biotransformation to another fluorescent product (Boudergue et al. 
2009). Recently, fumonisin esterase (FUMzyme®), an enzyme-based feed additive produced from a 
genetically modified strain of Komagataella pastoris, which is intended to degrade fumonisin mycotoxins 
found as contaminants in feeds for growing pigs has been approved by EFSA. Metabolites of fumonisin B1 
produced by the action of the active agent have a lower toxicity than the parent compound. Thus, it is 
considered safe for consumers of pigs and pork product (EFSA FEEDAP Penel 2014). 
 
Other suggestions of animal feed additive have been made for Trichosporon mycotoxinivorans, a yeast strain 
showing the potential to detoxify or degrade OTA and ZEA (Molnar et al. 2004). ZEA is degraded by the 
yeast to be carbon oxide and other non-toxic metabolites while OTA is detoxified with the cleavage of the 
phenylalanine moiety from the isocumarin derivate ochratoxin α. This metabolite has been described to be 
non-toxic or at least 500 times less toxic than the parent compound (Molnar et al. 2004). However, with 
transformation of mycotoxins by microorganisms, their application in detoxification of animal feeds has 
been limited. This may be due to the lack of information about mechanisms of transformation, toxicity of 
transformation products, effects of the transformation reactions on nutritional values of the feeds as well as 
the safety towards animals (Boudergue et al. 2009). Fermentation procedures with microorganisms can be 
used to detoxify mycotoxin contaminated feed. However, these have not yet been used in practice though the 
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number of corresponding patents has increased (Duvick and Rood 2000). The microorganism conversion is 
generally slow and incomplete (Karlovsky 1999; Sweeney and Dobson 1998). 
 
Conclusions 
 
Mycotoxins are presenting in farming, feed manufacturing and food production, and many are harmful to 
animals and if not fatal they can importantly impact on their performances and productivity. In order to 
reduce the exposure of animals and humans to mycotoxins, necessary practices such as the prevention of the 
occurrence of mycotoxins in the first place, ensuring the consistent quality of raw feed materials, and the 
implementing and verifying the effectiveness of control and test procedures should be fully considered. 
However, high concentrations of those mycotoxins may still exist in food and feed ingredients spite the best 
of efforts. It is also difficult to predict the concentration of the mycotoxin precisely in a large bulk lot 
because of the heterogeneity of their distribution in commodities i.e. clumping can occur, and the large 
variability associated with the overall mycotoxin isolation procedure. Therefore, it is crucial to continuously 
monitor food and feed ingredients with fast and reliable screening methods so that the extent of 
contamination can be fully and accurately determined and effective measures can be adopted at the relevant 
stages in the supply chain to mitigate such contamination should it occur. 
 
Drying and moisture control during storage is generally well understood as a control measure, in addition to 
identification of various crop genotypes that are resistant to mycotoxigenic fungus infection and the potential 
use of biocompetitive agents in different biological control strategies to prevent the pre-harvest mycotoxins 
particularly aflatoxin contamination of crops. 
 
Comprehensive food safety programs targeting both market vendor and local farmers may prevent or 
minimize the outbreaks of mycotoxin, especially aflatoxins. An occurrence of mycotoxins in agricultural 
commodities may continue to remain as a on the health and an economic issue caused in part by the 
complexity of the problem of masked mycotoxins, emerging mycotoxins and the problem of mycotoxin 
mixtures. 
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1.3. Objectives of the PhD thesis 
 
The thesis was aimed to: 
- Develop an intestinal “loop” model for studying mycotoxins toxicology (the model in 
between in vivo and ex vivo) 
- Compare the individual or combined effect of DON and NIV on jejunum segment at 
different concentrations in in vivo and ex vivo models 
- Identify and characterize the most sensitive and/or relevant biomarkers or the endpoints at 
different level of tissue to be used in each model 
 
1.4. The PhD thesis structure 
 
The thesis includes of three chapters: 
- Chapter I General background and objective of the work 
- Chapter II Materials and methods 
- Chapter III Results and discussion: paper 1, paper 2 and general discussion 
 
In Chapter III, the first published article is mainly based on the concordant results found at 4-h 
incubation between explant and loops model of the effect of individual DON and NIV. The second 
in-submitting article is based on the dose-response interaction analysis in loops and the confirmed 
concordant results found between 24-h-incubation loops and 28-day animal experiment of DON or 
DON combined with NIV. 
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Chapter II: Materials and Methods 
 
To achieve the thesis objectives, three biological experimental models (Fig. 3.) were used and 
various samplings were performed on pigs. The 3 experimental pig models are (i) Explant (ex-vivo), 
(ii) Loops surgical model (in vivo) and (iii) animal experiment (in vivo). 
 
 
Figure 3. The diagram illustrates the 3 biological models from pig and contaminations dosages used 
 
 
2.1. Biological models 
 
2.1.1. Explant model (Kolf-Clauw et al. 2009) 
 
Six pigs were used with 3 treatments at different levels of DON and NIV and DON+NIV (1:1) at a 
concentration of 0, 1, 3, and 10 µM in the culture medium. In total, 72 paraffin blocks (3 explants 
per block) were made. The methods for explant culture, toxin exposure, histological scoring, 
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histological processing, immunohistochemistry, architectural changes, proliferative and apoptosis 
indices are described in paper1. Sampling process is shown in Fig. 4. 
 
- Explant procedures 
Six 4-to-5-month-old crossbred piglets, housed in the animal facility of the INRA Toxalim, 
Research center in food toxicology, Toulouse, France, fed ad libitum with free access to water were 
used to obtain explants of jejunal tissue. The procedures of explant culture were performed as 
previously described in Kolf-Clauw et al. (2009) and Girard et al. (2005) with slight modifications. 
In brief, feed was deprived for 6 h prior to the explant procedures. A 5-cm middle jejunum segment 
was collected in prewarmed PBS added with 200 U/mL penicillin and 200 µg/mL streptomycin 
(Sigma, Saint-Quentin Fallavier, France). The jejunum was opened longitudinally, without 
removing external tunica muscularis and washed for 10 min at 39 °C, in culture medium contained 
with 200 U/mL penicillin and 200 µg/mL streptomycin. Sterilized biopsy punch (Stiefel 
laboratories LTD., Sligo, Ireland) was used to dissect the segment into 6 mm-piece diameter 
explants. All these operations were achieved in less than 1 h after the pig had been euthanized. 
 
The pigs jejunal explants were incubated villi up in 6-well culture plates (Nunclon, Sigma) for 4 h 
in the complete cell culture medium, Williams E at 37 °C prewarmed and gassed under CO2-
controlled atmosphere, 95% O2/5% CO2 with orbital shaking. The medium (WME), contains 100 
U/mL penicillin, 100 µg/mL streptomycin and 50 µg/mL gentamicin and supplemented with D-
glucose (2.5 g/L) and 30 mM Alanine-Glutamine (Sigma). Three explants per well were incubated 
on 1-cm2 biopsy sponge, in standard culture conditions. 
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Figure 4. The process of explants sampling. (A) Sampling jejunum segment. (B) Punching jejunum 
segment opened. (C) Explants treated with the mycotoxins solutions. (D) Paraffin blocks of 
included explants. (E) A microtome for slicing the explant blocks. (F) The slides ready for viewing 
under a microscope. 
 
 
2.1.2. Loops model (Gerdts et al. 2001) 
 
Five pigs were used for surgery of the jejunal loops; three pigs were sampled for 4h and two pigs 
24h after injection of mycotoxin into loops. Eleven loops were made, nine of which treated with 
different concentrations and two of which were control loops. Each pig, one normal intestinal 
segment (non-loop) was also sampled. Each loop was injected with 3 mL mycotoxin solution of 
DON and NIV and DON+NIV (1:1) at a concentration of 0, 1, 3 and 10 µM. In total, 70 paraffin 
blocks (3 pieces of intestinal segment per block) were made. The methods for loops incubation, 
toxin exposure, histological processing, immunohistochemistry, architectural changes, proliferative 
and apoptosis indices are described in paper 1 and 2. 
 
- Loops surgical processes and procedures 
Five 2-month-old Large White female pigs weighing 20-25 kg, maintained in warmed 
compartments with straw, fed with pelleted stock diet (Sevryplus-SANDERS) were used. Animals 
were fasted for 6 h prior to surgery but the pigs had full access to water. The loop surgery was 
performed as described in Girard-Misguich et al. (2011) and Gerdts et al. (2001). In short, for 
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anaesthesia, premedication was started with an intra-muscular (IM) injection of 2 mg/kg bw 
Xylazine (Rompun® 2%, Bayer-Schering AG, Leverkusen, Germany) with 20 mg/kg bw ketamine 
(Imalgene® 1000, Merial SAS, Villeurbanne, France). The animals were intubated using a cuffed 
endotracheal tube (Rüsch, Waiblingen, Germany) and anaesthesia was maintained with closed 
circuit of Isoflurane 3% and oxygen and ventilated with a veterinary anesthesia ventilator (Model 
2000, Hallowell EMC, Pittsfield, MA, USA)  in volume-controlled mode (100% oxygen). 
 
After cleaning and disinfection of the abdomen, a midline abdominal incision was made and a 100-
150 cm long segment of intestine was exteriorized and surgically prepared in the jejunum, where 
Peyer’s Patches could rarely be individualized. Eleven loops, each 10-12 cm in length with 2-3 cm 
interloop in between were produced from one pig through the mesentery without damaging grossly 
visible mesenteric arcades and thus maintaining full blood supply for both loops and interloop 
segments (Fig. 5.). An end-to-end anastomosis was made to maintain the intestinal flow from 
duodenum to jejunum and ileum in the gut besides the isolated loops. Before producing the loops, 
ingesta in the prepared jejunal segments were removed by flushing 2 times with a warm 100 mL 
physiological water solution. The exteriorized jejunum was frequently moistened with sterile 
physiological serum. The created-jejunum segments were in situ maintained and the midline 
abdominal incision was closed with U-shape interrupted sutures (peritoneum and muscles or 
abdominal wall) and the continuous sutures (skin). Pigs were treated with 0.15 mg/kg IM analgesic 
buprenorphine (Buprecare, Animalcare, Dunnington York, UK) immediately after the operation had 
been finished. The surgery lasted for almost 2 h per pig. 
 
After 4 h (3 pigs) and 24 h (2 pigs) post-surgery, the pigs were intravenously (IV) euthanized by 
barbiturate overdose to collect created jejunum-loop segments. Jejunal loops were quickly collected 
and washed twice with physiological serum prior to be fixed within 10% formalin. 
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Figure 5. Surgical creation of intestinal segment (A) and loops (B/I). The intestinal segment at 100-150 cm 
long was separated from the jejunum, which was then rejoined with an end-to-end anastomosis (B/II). The 
intestinal segment was subdivided into 11 loops per pig. Each loop was 10-12 cm long with 2-3 cm 
interloops (B/III).  
 
 
2.1.3. Animal experiment 
 
Two different animal experiments each carried out at 2 different locations (Arvalis, Vendome and 
Toxalim, Toulouse) with 24 pigs (male and female) and with duration of 28 days per each, and a 
total of 48 pigs were sampled. Four treatments were designed with DON, DON+NIV and DON+. 
The animals were fed with naturally contaminated feed. The exposed groups were Control (Similar 
to non-contaminated feed), DON at 2.89 mg.kg-1 feed, DON 3.5 mg.kg-1 + NIV 0.72 mg.kg-1 feed 
and DON+ at 4.3 mg.kg-1 feed. Samples were taken from 9 organs such as duodenum, jejunum, 
ileum, Peyer’s patch jejunum, colon, thymus, liver and mesenteric lymph nodes. There were 432 
samples embedded in paraffin block in total from 48 pigs. In the experiment conducted at Toxalim, 
pigs (n=24) were blood sampled at day0 (the first day) before feeding, at day7 and at day28 (the end 
of the experiment). The parameters (Fig. 6.) examined in vivo were growth performance, feed 
intake, clinical biochemistry: blood total protein, albumin, fibrinogen, Gamma-glutamyl transferase 
(GGT). The animal housing conditions and experimental protocols are described in paper 2. The 
results and discussions will be mainly focused excluding the DON+ treatment due to the realistic 
contamination of the mycotoxin. 
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Figure 6. The diagram showing parameters for sampling in the animal experiment.  
 
 
2.2. Histological assessment 
 
2.2.1. Morphometry 
 
The jejunum segments from the three biological models were used for an assessment. The explants 
were assessed by a morphological scoring system. The loops (4h and 24 h) and the animal 
experiment were assessed by measuring villus height and crypt depth. The assessment and 
measurement protocols are described in paper 1. 
 
2.2.2. Immunohistochemistry 
 
The tissues from loops model (jejunum segment) and from animal experiment (jejunum and Peyer’s 
patches jejunum) were processed for histology and immunohistochemistry (for proliferation; Ki-67 
and apoptosis; caspase-3). The procedures of this process are described in paper 1 and paper 2. The 
intestinal crypts were first chosen for proliferative enterocyte count, and then followed by total-cell 
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proliferation and total-cell apoptosis count, finally the proliferative enterocyte and apoptotic 
enterocyte counts at the tip of the villi. 
 
2.3. Gene expression (qRT-PCR) 
 
Since DON acts on intestinal immunomodulation and junction protein genes, we investigated the 
effects of DON by using qRT-PCR (quantitative Real-Time Polymerase Chain Reaction) analysis in 
loops model. In the jejunum segments, treated at 10 µM DON (4 h and 24 h), were determined the 
expression of mRNA encoding for IL-1α, IL-1β, IL-6, IL-8, IL-10, IL12-p40, IL-21, TNF-α, TGF-
β, CCL-20, IFN-γ, EDN-2, NF-κB, ALP, TLR-1, TLR-2, TLR-5, TLR-9, PCNA, Lysozyme, ZO-1, 
E-cadherin, Occludin, Claudin-1, Claudin-2, Claudin-3, Claudin-4 (Table 3.). The cyclo A and β-
actin were used as housekeeping genes to normalize the values obtained. The genes expression was 
calculated relative to the control treatment. The protocols were previously described in Cano et al. 
(2013). Briefly, the jejunum tissue pieces stored at -80 °C after fixing in liquid nitrogen, were 
extracted with Trizol Reagent (Extract all, Eurobio) for total RNA. RNA quality, concentration and 
integrity were assessed spectrophotometrically using Nanodrop ND1000 (Labtech International, 
Paris, France). Then, the steps of reverse transcription and real-time qPCR were performed as 
described in Meissonnier et al. 2008. To verify genomic DNA amplification signal, non-reverse 
transcripted RNA was used as non-template control. Finally, dissociation curves were analyzed and 
assessed for the specificity of qPCR products after the reactions. Primers were purchased from 
Invitrogen (Invitrogen, Life Technologies Corporation, Paisley, UK). The DDCt method was used 
to determined amplification efficiency and initial fluorescence. 
 
Table 3. List of genes used in qTR-PCR and theirs primer sequences (F: forward, 5'3'; R: reverse, 3'5'). 
Gene symbol Gene name Primer sequence 
Accession number 
(reference) 
IL-1α Interleukin 1 - alpha 
F: TCAGCCGCCCATCCA NM_214029,1 
R: AGCCCCCGGTGCCATGT (Cano et al. 2013) 
IL-1β Interleukin 1 - beta 
F: ATGCTGAAGGCTCTCCACCTC NM_214055 
R: TTGTTGCTATCATCTCCTTGCAC (Von der Hardt et al. 2004) 
IL-6 Interleukin 6 
F: TTCACCTCTCCGGACAAAACTG NM_214399 
R: TCTGCCAGTACCTCCTTGCTGT (Gourbeyre et al. 2014) 
IL-8 Interleukin 8 
F: GCTCTCTGTGAGGCTGCAGTTC NM_213867 
R: AAGGTGTGGAATGCGTATTTATGC (Grenier et al. 2011) 
IL-10 Interleukin 10 
F: TGAGAACAGCTGCATCCACTTC NM_214041 
R: TCTGGTCCTTCGTTTGAAAGAAA (Royaee et al. 2004) 
IL12-p40 Interleukin 12 p40 
F: GGTTTCAGACCCGACGAACTCT NM_214013 
R : CATATGGCCACAATGGGAGATG (Cano et al. 2013) 
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IL-21 Interleukin 21 
F: GGCACAGTGGCCCATAAATC MN_214415 
R: GCAGCAATTCAGGGTCCAAG (Kiros et al. 2011) 
TNF-α Tumor necrosis factor - alpha 
F: ACTGCACTTCGAGGTTATCGG NM_214022 
R: GGCGACGGGCTTATCTGA (Meissonnier et al. 2008) 
TGF-β Transforming growth factor - beta 
F: GAAGCGCATCGAGGCCATTC NM_214015 
R: GGCTCCGGTTCGACACTTTC (Meurens et al. 2009) 
CCL-20 Chemokine (CCL20) 
F: GCTCCTGGCTGCTTTGATGTC NM_001024589 
R: CATTGGCGAGCTGCTGTGTG (Meurens et al. 2009) 
IFN-γ Interferon - gamma 
F: TGGTAGCTCTGGGAAACTGAATG NM_213948 
R: GGCTTTGCGCTGGATCTG (Royaee et al. 2004) 
EDN-2 Endothelin 2 
F: TACTTCTGCCACTTGGACATCATC ENST00000372587 
R: GGCCGTAAGGAGCTGTCTGT (Gourbeyre et al. 2014) 
NF-κB Nuclear factor-kappa-B 
F: CCTCCACAAGGCAGCAAATAG ENSSSCT00000033438 
R: TCCACACCGCTGTCACAGA (Present study) 
ALP alkaline phosphatase 
F: AAGCTCCGTTTTTGGCCTG ENSSSCT00000017732 
R: GGAGGTATATGGCTTGAGATCCA (Gourbeyre et al. 2014) 
TLR-1 Toll-like receptor 1 
F: TGCTGGATGCTAACGGATGTC AB219564 
R: AAGTGGTTTCAATGTTGTTCAAAGTC (Arce et al. 2010) 
TLR-2 Toll-like receptor 2 
F: TCACTTGTCTAACTTATCATCCTCTTG AB085935 
R: TCAGCGAAGGTGTCATTATTGC (Gourbeyre et al. 2014) 
TLR-5 Toll-like receptor 5 
F: CCTTCCTGCTTCTTTGATGG NM_001123202 
R: CTGTGACCGTCCTGATGTAG (Meurens et al. 2009) 
TLR-9 Toll-like receptor 9 
F: CACGACAGCCGAATAGCAC AY859728 
R: GGGAACAGGGAGCAGAGC (Arce et al. 2010) 
PCNA Proliferating cell nuclear antigen 
F: GTTGATAAAGAGGAGGAAGCAGTT ENSSSCT00000032581 
R: TGGCTTTTGTAAAGAAGTTCAGGTAC (Gourbeyre et al. 2014) 
Lysozyme Lysozyme 
F: GGTCTATGATCGGTGCGAGTTC ENSSSCT00000034939 
R: TCCATGCCAGACTTTTTCAGAAT (Gourbeyre et al. 2014) 
ZO-1 Zonula occludens-1 
F: ATAACATCAGCACAGTGCCTAAAGC AJ318101 
R: GTTGCTGTTAAACACGCCTCG (Present study) 
E-cadherin E-cadherin 
F: ACCACCGCCATCAGGACTC ENSSSCG00000006369 
R: TGGGAGCTGGGAAACGTG (Present study) 
Occludin Occludin 
F: AGCTGGAGGAAGACTGGATCAG U79554 
R: TGCAGGCCACTGTCAAAATT Yamagata et al. 2004 
Claudin-1 Claudin-1 
F: GGGCAGATCCAGTGCAAAGT AJ318102 
R: GGCTATTAGTCCCAGCAGGATG (Present study) 
Claudin-2 Claudin-2 
F: CAGCATGAAATTTGAGATCGGA NM_001161638.1 
R: GAGGAAATGATGCCCAAGTAGAGA (Present study) 
Claudin-3 Claudin-3 
F: CTGCTCTGCTGCTCGTGCCC AY625258 
R: TCATACGTAGTCCTTGCGGTCGTAG (Present study) 
Claudin-4 Claudin-4 
F: CTGCTTTGCTGCAACTGCC AK233156 
R: TCAACGGTAGCACCTTACACGTAGT (Present study) 
Cyclo A Cyclophilin A 
F: CCCACCGTCTTCTTCGACAT NM_214353 
R: TCTGCTGTCTTTGGAACTTTGTCT (Curtis 2009) 
β-actin beta actin 
F: TCATCACCATCGGCAACG AY550069 
R: TTCCTGATGTCCACGTCGC (Von der Hardt et al. 2004) 
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Abstract: The mycotoxins deoxynivalenol (DON) and nivalenol (NIV), worldwide cereal 
contaminants, raise concerns for animal and human gut health, following contaminated food 
or feed ingestion. The impact of DON and NIV on intestinal mucosa was investigated after 
acute exposure, in vitro and in vivo. The histological changes induced by DON and NIV 
were analyzed after four-hour exposure on pig jejunum explants and loops, two alternative 
models. On explants, dose-dependent increases in the histological changes were induced by 
DON and NIV, with a two-fold increase in lesion severity at 10 µM NIV. On loops, NIV 
had a greater impact on the mucosa than DON. The overall proliferative cells showed 30% 
and 13% decrease after NIV and DON exposure, respectively, and NIV increased the 
proliferative index of crypt enterocytes. NIV also increased apoptosis at the top of villi and 
reduced by almost half the proliferative/apoptotic cell ratio. Lamina propria cells (mainly 
immune cells) were more sensitive than enterocytes (epithelial cells) to apoptosis induced 
by NIV. Our results demonstrate a greater impact of NIV than DON on the intestinal mucosa, 
both in vitro and in vivo, and highlight the need of a specific hazard characterization for NIV 
risk assessment. 
Keywords: mycotoxins; jejunum explant; loops; deoxynivalenol; nivalenol; enterocytes; 
histomorphology 
 
1. Introduction 
Fungi of the Fusarium genus commonly contaminate cereals in the temperate climatic zones of the 
world and contribute to poor quality grains entering the feed and food chain. Among the mycotoxins 
produced by Fusarium, the large group of trichothecenes is extremely prevalent, particularly 
deoxynivalenol (DON) for which many exposure and toxicological surveys have been carried out or 
reviewed recently [1,2]. Nivalenol (NIV), classified with DON as a type B trichothecene, is a 
biologically active metabolite of DON, present in agricultural commodities [3,4]. A large-scale data 
survey has indicated that DON and NIV are present in 57% and 16%, respectively, of food samples 
collected in the European Union [5].  
From their first discovery, there has been concern about the relationship between trichothecenes 
exposure and health damage based on both experimental toxicity and epidemiological data. Studies have 
shown that mycotoxins cause toxic effects in humans as well as in all animal species so far investigated, 
the pig being the most sensitive species [6]. Studies in laboratory and farm animals have revealed a 
complex spectrum of toxic effects. Experimentally, low to moderate acute oral exposure to 
trichothecenes cause vomiting, diarrhea and gastroenteritis, whereas higher doses cause severe damage 
to the lymphoid and epithelial cells of the gastrointestinal mucosa resulting in hemorrhage, endotoxemia 
and shock. Chronic exposure to trichothecenes can cause anorexia, reduced weight gain, diminished 
nutritional efficiency, neuroendocrine changes, and immune modulation. Although not as prevalent as 
DON [7], NIV showed higher acute toxicity than DON in animal studies, with oral LD50 values in mice 
of 78 and 39 mg·kg−1 for DON and NIV, respectively [8]. NIV is of added concern for food safety but 
in vivo information for assessing the health risk remain scarce, and NIV toxicity is considered similar to 
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DON toxicity for protecting human health [9]. At the molecular level, DON and NIV, like other 
trichothecenes, display multiple inhibitory effects on the primary metabolism of eukaryotic cells 
including the inhibition of proteins, DNA and RNA synthesis [10]. This impairment leads to altered cell 
proliferation in tissues with high rates of cell turnover such as spleen, bone marrow, thymus and 
intestinal mucosa [11].  
Following ingestion of contaminated feed or food, the intestine and intestinal mucosa can be exposed 
to a high concentration of food contaminants, such as mycotoxins [12]. However, only a few studies 
have investigated the effects of mycotoxins on this target, even though there is increasing evidence that 
intestinal epithelium is repeatedly exposed to mycotoxins at a higher concentration than other  
tissues [13]. Pigs receiving 3 mg/kg feed of DON for five weeks showed significant histopathological 
changes compared to control animals, such as atrophy and fusion of villi and reduction of the number of 
goblet cells and lymphocytes [14]. Little is known about the effects of NIV on the intestinal tract of pigs. 
Pigs receiving 2.5 or 5 mg NIV/kg of feed for three weeks, showed gastrointestinal erosions [15] and 
reduced enzymatic ability of the intestinal epithelium [16].  
In the context of implementing the 3Rs, “Replace, Reduce, Refine” [17], in vitro and in vivo 
alternatives can be used to reduce the number of experimental animals. An intestinal explants-in vitro 
model and an intestinal loops-in vivo model have been developed for studying intestinal responses to 
pathogens [18,19]. The culture of intestinal explants allows preservation of the normal histological 
structure in vitro [20]. The pig jejunal explant model has previously been used to study the digestive 
effects of the mycotoxin DON [21–23], and to analyze the toxicity of mixtures of mycotoxins [24]. The 
present work was designed to compare the acute impacts of DON and NIV on pig jejunal mucosa. The 
above two models were used in parallel. First, a dose-response study with explants was carried out to 
estimate the toxic dose for DON and NIV on the mucosa, then, jejunal loops were injected with the two 
toxins at the selected toxic dose. In the two models, the results, assessed after 4-h of exposure, were 
concordant, showing a greater impact of NIV compared to DON on the intestinal mucosa. 
2. Results  
2.1. Explants Model  
2.1.1. Histological Analysis before and after Incubation and Effect of DMSO 
First, the effects of the culture and of DMSO on the histology of the jejunal explants were 
investigated. The explants were observed microscopically and scored from 22 (no lesion) to 0. Before 
incubation (T0), the scores were between 16 and 21 for all explants (Figure 1 panel I). The histological 
lesions observed were mild edema in the lamina propria and slight dilatation of the lymphatic vessels, 
resulting in an average score of 18 ± 2 (Figure 1 panels I and IIa). 
After incubation in Williams E Medium (WME) for 4 h, with or without DMSO, the scores did not 
differ significantly from those of the non-incubated explants (Figure 1I), although flattened villi were 
apparent after this incubation period (Figure 1IIb). The mean villus height was 141 ± 29 µm in the 
explants incubated with WME alone and 147 ± 41 µm in the explants incubated with DMSO and did not 
differ significantly from the T0 results. No statistically significant difference was observed between the 
different incubation groups, with 0.1% DMSO, or without DMSO (Figure 1I). The scores of control 
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explants with or without DMSO were grouped into a single 4-h culture control group for subsequent 
analyses (n = 84). 
 
Figure 1. Histological scores of jejunal explants. (I) Explants exposed to different 
treatments: T0 (Time 0H, before culture ), T4/WME (4 h in William’s medium E), T4/WME 
+ 0.1%DMSO (dimethylsulfoxyde), DON (deoxynivalenol) or NIV (nivalenol): 1, 3 and  
10 µM. Values are mean ± SEM. (II) Effect of DON and NIV on the histological score after 
4 hours of exposure. Values are mean ± SEM. a, b, c scripts are different at p ≤ 0.05 by 
Tukey’s test (II) (a) Jejunal explant uncultured (T0; n = 12). Slight dilatation of the 
lymphatic vessels (arrow), HE (hematoxylin-eosin), ×200; (b) explants exposed to WME 
with 0.1% DMSO (DMSO n = 42). Edema of the lamina propria and mild villus atrophy 
(arrow), HE ×200; (c) 3 µM DON-exposed explant. Moderate fusion and cubic epithelial 
cells (arrow) (HE, ×200); (d) 10 µM NIV-exposed explant. Fusion and atrophy of villi with 
severely flattened epitelium (arrow) and apical denudation of villi (dotted arrow) (HE, ×200). 
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2.1.2. Effect of Mycotoxins on the Histological Scores 
Each treatment, DON (1–10 µM) and NIV (1–10 µM) induced a dose-dependent decrease in the 
histological scores of the jejunal explants after 4 h of exposure (p < 0.01) (Figure 1II). In the explants 
exposed to DON, the main morphological change was coalescence with moderate fusion of villi. Lesions 
included cubic epithelial cells instead of the cylindrical epithelial cells seen in the control, areas of edema 
in the lamina propria, villus atrophy and apical denudation of villi with focal loss of apical enterocytes 
(Figure 1IIc). In the group treated with NIV, the changes were similar to those of the group exposed to 
DON but both the flattening of the epithelial cells and apical denudation of the villi were more severe 
(Figure 1IId). The individual treatments with the mycotoxins DON and NIV resulted in a significant 
decrease of the histological score from doses of 3 µM and 1 µM, respectively. The corresponding scores 
were reduced to about 70% of the control explants by 3 µM and 10 µM DON or 1 µM NIV, to almost 
half the mean score of control explants (59% ± 6%) by the highest NIV concentration (Figure 1II).  
So, NIV showed greater toxicity than DON in the explant model, with a lowest observed effect 
concentration of 1 µM. 
 
Figure 2. Jejunum morphology in a non-loop segment (a) and in a control loop (b) showing 
vascular changes in the submucosa (large arrow) and edema of the villi central lymphatic 
vessels (thin arrows); (c) Ki-67 immunostaining in a control loop, showing the methodology 
for morphometric and proliferation assessments. 
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2.2. Loops Model 
2.2.1. Comparison of Loops Segments with Non-Loops Segments 
The surgery induced vascular disorders in the loops, more pronounced in the serosa and submucosa 
layers, with moderate interstitial edema, congestion, focal blood extravasation and moderate focal 
dilation of the central lacteal in the villi tips (Figure 2b). The proliferation and apoptosis counts did not 
differ between the control loops and non-loops segments, and were subsequently used as endpoints after 
toxins exposure. 
2.2.2. Effect of DON and NIV Exposure on Morphometry in the Loops 
The mean crypt-depth to villus-height ratios after DON (0.99 ± 0.15) and NIV (1.01 ± 0.16) 
treatments were increased by 15%–20% compared to the control ratio (0.86 ± 0.11) without significant 
difference between DON and NIV (Figure 3). 
 
Figure 3. Morphometric analysis of the jejunum loops: crypt-depth to villus-height ratio 
after DON and NIV exposure at 10 µM for 4 h. Mean values ± SEM expressed as % of the 
control group; a, b scripts are different at p ≤ 0.05; Tukey’s test; n = 3 to 6 loops,  
30 well-oriented villi and crypts per loop. 
2.2.3. Effect of DON and NIV Exposure on Proliferation in the Loops 
At the villus tip, a significant decrease was observed in the total cells proliferation compared with 
control loops. NIV exposed loops showed a significant 30% decrease in the number of cells proliferating 
in the mucosa (p < 0.001), while DON-exposed loops showed a 13% decrease compared with the 
controls (Figure 4A). At the crypt level, proliferative index of crypt enterocytes was increased only after 
NIV treatment (p = 0.001, Figure 4B). 
2.2.4. Effect of DON and NIV Exposure on Apoptosis in the Loops 
At the villus tip, the number of total apoptotic cells was higher in NIV-exposed loops than in the 
controls. A tendency was detected for the enterocyte apoptotic index (p = 0.057) with mean values of 
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2.36% ± 1.12%, 2.57% ± 1.52% and 3.43% ± 2.55% for the control, DON and NIV, respectively. The 
total-cell proliferation to total-cell apoptosis ratios at villus tip showed a significant decrease (p < 0.001) 
with values of 6.98 ± 1.84, 5.60 ± 1.65 and 3.89 ± 1.2 for the controls, DON and NIV, respectively. NIV 
reduced the total-cell proliferation to total-cell apoptosis ratio at the tip of the villus by 44% compared 
to the controls, while DON reduced this ratio by only 20% (Figure 4D).  
In lamina propria, the number of apoptotic cells was significantly increased by NIV (p < 0.001, 
Figure 4C).  
 
Figure 4. Proliferation and apoptosis in the jejunum loops after DON and NIV exposure at 
10 µM for 4 h. Mean values ± SEM expressed as % of the control group (Ctrl) (A) total cell 
proliferation at villus tip (upper one-third), p < 0.001; (B) proliferative index of crypt 
enterocytes, p = 0.001; (C) lamina propria apoptosis at villus tip (upper one-third),  
p < 0.001; and (D) total proliferating cells to total apoptotic cell ratio, at villus tip p < 0.001. 
a, b, c scripts are different at p ≤ 0.05; Tukey’s test; n = 3 to 6 loops, 20 villi/loop. 
3. Discussion 
Two alternative models were used in this study to analyze intestinal mucosal toxicity, a major target 
for xenobiotics. An explant model, previously shown to be sensitive [23,24], was first used to 
demonstrate dose-related toxicity following in vitro exposure to DON and NIV, and a higher toxicity of 
NIV. This result was then confirmed in vivo, using the intestinal loops model.  
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3.1. The Jejunum Explants and Loops Alternative Models Reduce the Number of Animals 
These two alternative models enabled to reduce the number of animals in experiments, according to 
the 3Rs recommendations, as the explants or loops are the experimental unit and not the whole animal. 
Pig intestinal explant culture represent a relevant model for investigating the effects of feed and food 
contaminants, due to the relevance of the pig model-species in relation to humans, and its high sensitivity 
to mycotoxins. In the current study, before analyzing the effects of the mycotoxins DON and NIV on 
the scores, the histological scoring was refined and demonstrated the absence of impact of DMSO up to 
0.1% as solvent. This study illustrates for the first time, to the best of our knowledge, the use of intestinal 
loops in toxicology. However, the scoring system developed for the explants was not suitable to use in 
the loops model, because of the inter-loops variations brought about by the surgery-induced vascular 
changes (edema in the lamina propria). Proliferation and apoptosis were used to assess the in situ 
mucosal changes, being quantifiable biomarkers specifically affected in vitro and in vivo by the 
trichothecenes [14,25–28].  
3.2. Acute Exposure to NIV More Toxic in Vitro on Jejunum Mucosa than DON 
Our study revealed higher intestinal mucosa changes after acute exposure to NIV than to DON 
exposure, both in vitro and in vivo. Following in vitro 4-h single exposure, both trichothecenes induced 
a dose-related decrease of the explants scores, NIV showing a higher toxicity than DON. Significant 
changes were observed in explants exposed to 3 and 10 µM DON. The main histological changes were 
focal enterocyte desquamation, moderate atrophy and fusion of villi, in accordance with previous  
studies [21,23,27]. The 30% reduction of the histological score following 10 µM DON was similar to 
the results obtained by Basso et al. [21] who reported a 37% decrease of the histological score. In our 
experiment, all doses of NIV significantly affected the histological scores of the explants. NIV toxicity 
on intestinal cells in vitro has already been reported. For example, NIV decreased dose-dependently the 
viability of Caco-2 and IPEC-J2 cells [29,30]. In a previous study, the reduction of IEC-6 viability due 
to treatment with NIV was related to apoptosis induction [26]. The less severe toxic effect of DON,  
as compared to NIV, on intestinal explants is also in accordance with previous studies, which 
demonstrated that NIV exerted a stronger effect than DON on both intestinal and non-intestinal cell  
lines [26,28,29,31,32].  
3.3. Acute Exposure to NIV More Toxic in Vivo on Jejunum Mucosa than DON 
In the loops model, as in the explants study, the intestinal toxicity of NIV was higher than that of 
DON. At 10 µM, both DON and NIV increased the crypt-depth to villus-height ratios, reflecting 
intestinal damage in vivo, as described in conventional animal experiments [33]. At 10 µM, DON and 
NIV induced in vivo lamina propria apoptosis and decreased total cells proliferation at the villus tip in 
the loops model, while only NIV increased the enterocytes proliferation index at the crypt level. So, our 
study shows that the lamina propria cell populations are the most sensitive target of the jejunum mucosa, 
after DON and NIV exposure. The major cell populations of lamina propria, besides connective tissue 
cells, are immune cells, with high proliferative rate, recognized as the most sensitive cells to DON 
toxicity. These targets have been previously described to explain the modulation of the intestinal immune 
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response induced by DON and other trichothecenes [34]. Few studies have analyzed the action of NIV 
on intestinal morphology. Chronic ingestion of NIV induced gastrointestinal erosions in young pigs  
(2.5 or 5 mg/kg) [15], whereas C57BL/6 mice exposed to NIV subchronically or chronically by feeding 
did not show any alterations in the histological architecture of small intestine [35,36]. These differences 
could be related to the highest sensitivity of the pig, reported to be the most sensitive species to 
mycotoxins [6,37]. In the present study, the proliferation mucosal response at crypt level was significant 
for NIV. These results are in accordance with previous comparative studies of the two toxins, in vitro or 
in vivo, with other endpoints than the intestinal target. For example, NIV showed higher anorectic 
potency in mice [38].  
3.4. DON and NIV Induced Apoptosis in Vivo on Loops 
The intestinal effects observed after 4-h exposure to DON and NIV can be mediated by oxidative 
stress, inducing intestinal cell membrane alteration and apoptosis. DON-induced oxydative stress has 
been shown in splenic tissue in a rodent model [39], as well as lipid peroxidation in vitro in HepG2 cells 
exposed to levels similar to the present study [40]. The alterations caused by DON in jejunal explants 
have been correlated to MAPKs signaling pathway activation [22], and to up-regulation of  
pro-inflammatory cytokines [41]. 
3.5. Relevance of the Results for Risk Characterization 
The effects of mycotoxins were assessed at realistic concentrations in the present study, considering 
the concentrations of mycotoxins to which the consumer can be exposed via food. The results are 
therefore of high relevance for risk characterization of DON and NIV exposure. DON concentrations of 
0.16–2 μg/mL (0.5–7 μM) in the human gut can be considered as realistic [42]. The lower concentration 
corresponds to the mean estimated daily intake of French adult consumers on a chronic basis [43]. The 
higher concentration is the simulated levels that can be attained after the consumption of heavily 
contaminated food, and is occasionally encountered. The amount of NIV in cereal products varies 
considerably between different countries across the world (from 20–60 µg/kg in France, to  
584–1780 µg/kg in China) [44]. Significant architectural and lesional alterations were observed from 
doses of 1 µM NIV in this study, which is consistent with the levels plausibly encountered in the 
gastrointestinal tract after the consumption of heavily contaminated food.  
4. Materials and Methods  
4.1. Animals 
For explants sampling, six 4–5 week-old crossbred piglets were used, housed in the animal facility of 
the INRA ToxAlim Laboratory (Toulouse, France). For the loops experiment, three two-month-old 
Large White female pigs were used and housed in the animal facility at INRA Nouzilly. All animals 
were fasted for 6 h before explants sampling or loops surgery. The experimental procedures were 
conducted in accordance with European Guidelines for the Care and Use of Animals for Research 
Purposes and were approved by the INRA local ethical committees for animal experimentation  
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(C2EA-86 for explants, and “Comité d’Ethique en Expérimentation Animale Val de Loire”, C2EA-06, 
for the loops experiments). 
4.2. Toxins  
DON was acquired from Sigma (St Quentin Fallavier, France) and NIV from Waco Pure Chemical 
Industries LTD (Osaka, Japan). Stock solutions of these mycotoxins were dissolved in dimethyl 
sulfoxide (DMSO Sigma, Saint-Quentin Fallavier, France) at the following concentrations: 15 mM DON 
and 10 mM NIV for explants, and at 30 mM DON and NIV for the loops experiments. These stock 
solutions were stored at −20 °C. Working dilutions were prepared in William’s medium E (WME-Sigma, 
Saint-Quentin Fallavier, France) for the explants, and in physiological saline solution for the loops. The 
concentrations range for the dose-response explants study was 0–10 µM, selected after preliminary 
explants cultures with 0.1 to 30 µM of each toxin.  
4.3. Jejunum Explants Experiment (in Vitro) 
4.3.1. Jejunal Explants  
The procedure for the culture of explants was as previously described [23,24]. Explants were 
incubated for 4 h with WME at 37 °C under a CO2-controlled atmosphere with orbital shaking. 
Uncultured control tissue was placed in fixative immediately after dissection, as time 0 controls  
(T0, n = 12, two explants/pig). In view of the possible effects of DMSO on intestinal morphology,  
the final concentration of 0.1% DMSO corresponding to the highest DMSO concentration in the working 
dilutions was tested in 42 explants (with and without DMSO: 84 explants). Twelve explants were 
exposed to purified DON and NIV at each of the concentration 1, 3 and 10 µM, for 4 h, respectively 
(two explants/pig for each condition).  
4.3.2. Histological Scoring  
For histological analysis, the explants fixed in 10% formalin (VWR, Strasbourg, France) were 
embedded in paraffin (VWR) and sectioned at 3–5 µm thickness parallel to the villus axis and stained 
with hematoxylin (VWR) and eosin (CML, Nemours, France) (HE) using standard procedures.  
The resulting slides were analyzed independently by two observers, at 100× magnification.  
The histological changes were evaluated using a tissue scoring system [23] with minor modifications. 
The scoring system included both architectural and lesional criteria, as shown in Table 1. The maximum 
score was attributed to the T0 tissue, before incubation, for each criterion. The architectural score 
included the number of villi per explant and the fusion of villi. This latter was expressed as the 97.5th 
percentile of the percentage of fused villi (number of fused villi/non fused villi 100×). The score of 3 for 
villus fusion corresponded to a maximum of 11% fused villi. At least 25 villi needed to be counted per 
explant to obtain the score of 3.  
The lesional score included morphology of enterocytes (score 3 for columnar epithelium), the degrees 
of edema and apoptosis in the lamina propria (score 2 for slight flattening of villi), and the extent of 
discontinued epithelium qualified as apical denudation of villi. This endpoint was quantified by the 
97.5th percentile of the percentage of the villi showing apical denudation (score 3 for T0 explants).  
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For explants lesions, score 3 corresponded to a maximum of 10% apical denudation and scores of 2, 1, 
and 0, to 11%–40%, 41%–70%, and 71%–100%, respectively. For lesion of the lamina propria, 
localized edema was scored as 1, whereas multifocal edema and apoptosis were scored as 0. The total 
score was calculated by taking into account the degree of severity for the lesions (severity factor). For 
each lesion, the score (according to intensity or observed frequency) was multiplied by the severity factor 
of 2. The total score for each explant was then obtained from the sum of each criterion. Each score value 
was the result of 2 explants/pig/condition. The maximum score (22 points) indicated overall integrity of 
the intestine. The histological scoring system was applied to compare the microscopic changes observed 
after 4-h exposure of the explants to DON and NIV. 
Table 1. Explants histological scoring: endpoints used and severity factor. 
Score component Criteria (severity factor) End-point Score
Lesional part of the Score 
Enterocytes morphology (2) 
Columnar epithelium 3 
<50% cuboid epithelium 2 
>50% cuboid epithelium 1 
Flattened epithelium 0 
Apical denudation of villi (2) 
0%–10% 3 
11%–40% 2 
41%–70% 1 
71%–100% 0 
Lesions of lamina propria (2)
No lesions, slight flattening of villi 2 
Localized edema and apoptosis 1 
Multifocal edema and apoptosis 0 
Architectural part of the Score 
Villi fusion (1) 
0%–11% 3 
12%–40% 2 
41%–70% 1 
71%–100% 0 
Number of villi (1) 
≥25 3 
16–24 2 
5–15 1 
≤4 0 
4.4. Jejunum Loops Experiment (in Vivo) 
4.4.1. Jejunal Loops Injection and Sampling 
A 1-m long segment of intestine was surgically prepared in the jejunum, to constitute the loops as 
previously described [19,45]. This segment was then subdivided into consecutive segments, designated 
as “loops” (10 cm long, 6 loops), separated by “inter-loops”. Three treatments, control (Ctrl), DON and 
NIV at 10 µM concentration were used for each of the 3 pigs (1 to 2 loops/pig for each condition, n = 6 
loops for the controls) by injecting 3 mL of each test condition into each loop. Four hours after surgery, 
the pigs were euthanized by barbiturate overdose (pentobarbital, Vetoquinol, Lure, France) and the 
created jejunum-loop segments were collected. These loops were washed twice with physiological serum 
prior to fixation. In addition, a non-loop segment was sampled and processed in parallel. 
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4.4.2. Histological Processing 
A routine histological processing sequence (from 10% buffered formalin to paraffin block) was used. 
Paraffin sections 4-µm thick were stained with HE to assess architectural changes and 
immunohistochemically labeled (IHC) to assess proliferation and apoptosis. 
4.4.3. Immunohistochemistry 
Two commercial antibodies were used as previously described [46,47]. Briefly, four-micrometer 
paraffin-embedded transverse sections from formalin-fixed jejunum specimens were dewaxed in toluene 
and rehydrated by an acetone bath then deionized water. Antigen retrieval was performed in 10 mM 
citrate buffer pH 6.0 for 30 min in a water bath at 95 °C. Cooled sections were then incubated in Dako 
peroxidase blocking solution (Dako S2023) to quench endogenous peroxidase activity. Non-specific 
binding was blocked by incubation in normal goat serum (dilution 1:10, Dako X0902) for 20 min at 
room temperature. The primary antibodies were anti-Ki-67antigen (Dako M7240, dilution 1:50) and 
anti-active caspase-3 (R&D system, AF835, dilution 1:300). Sections were incubated with primary 
antibodies for 50 min at room temperature (RT). Bound primary antibodies were detected with 
EnVision™ + Horse Radish Peroxydase (HRP) Systems (Dako, K4061) 30 min at RT. Peroxidase 
activity was revealed by 3,3′-diaminobenzidine tetrahydrochloride substrate (Dako K3468). Finally, 
sections were counterstained with Harris hematoxylin, dehydrated and coverslipped.  
4.4.4. Architectural Changes 
Eclipse E400 Nikon microscope, with DS-FI camera driven by NIS-D element software (Nikon) was 
used to capture images (100× magnification) and take the measurements for architectural evaluation of 
the digestive mucosa. A total of about 30 well-oriented villi and crypts per loop were selected on each 
section. A villus was measured from the tip to the shoulder (crypt-villus junction) and a crypt was 
measured from the shoulder to its base (Figure 1c). The crypt-depth to villus-height ratio was calculated 
to assess the intestinal architectural changes. 
4.4.5. Proliferative and Apoptosis Indexes 
Proliferative and apoptotic cells were counted after immunohistochemistry in several sites on the 
mucosa. A minimum of 20 well-oriented villi and crypt units were assessed on scanned marked slides 
(Panoramic 250 Flash II–3D Histech), and analyzed with Pannoramic Viewer software (v. 1.15.2, 
3DHISTECH Ltd, Budapest, Hungary,). Proliferative cells were counted in the upper one-third of the 
villi, i.e. villus tip (positive cells/total cells: lamina propria plus epithelial cells), and in the bottom  
two-thirds of the crypts from the basis (proliferative index of crypt enterocytes) (Figure 1c).  
For apoptosis, the total cells counts, lamina propria counts and villus enterocytes counts were measured 
in villus tip (upper one-third). The enterocyte apoptotic index was calculated by dividing the positive 
enterocyte number by the total number of enterocytes (×100) in the villus tips while the proliferative 
index of crypt enterocytes was calculated by dividing the number of positive enterocytes by the total 
number of enterocytes (×100) in the crypt bases (Table 2). 
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Table 2. Summary of the cell counts and indexes used for assessing proliferation and 
apoptosis in loops. 
Endpoint 
Counted 
area  
(Figure 2) 
Cells counts Indexes 
Proliferation  
 Villus tip 
Total cells: lamina 
propria cells + 
enterocytes 
 
 Crypt bases Crypt enterocytes  
Proliferative index of crypt enterocytes: 
number of positive enterocytes/total number of 
enterocytes (×100) 
Apoptosis  
 Villus tip 
Enterocytes  
Lamina propria cells 
(mainly immune cells) 
Total cells: lamina 
propria + enterocytes 
Enterocyte apoptotic index: number of positive 
enterocytes/total number of enterocytes (×100) 
Ratio 
Proliferation/Apoptosis 
 
 Villus tip 
Total cells: lamina 
propria cells + 
enterocytes 
Total-cell proliferation  
to total cell apoptosis ratio 
4.5. Statistical Analysis 
The two experiments were designed as randomized blocks. The explants and loops data are presented 
as means ± SEM, expressed as percentages of the control values. Plots of fits versus residuals followed 
by Bartlett’s test, and normal plots of the residuals by Anderson-Darling’s test were carried out to 
confirm the assumptions of homogeneity of variances and the normal distribution of residuals, 
respectively. If these assumptions did not hold, the data were normalized and homogenized by log10 or 
square root transformation prior to being analyzed. All tests were performed using the MINITAB 
package software (V.13.0, Minitab Inc., State College, PA, USA). The data were analyzed by applying 
the GLM option of ANOVA analysis, followed by pairwise comparisons, Tukey’s or Bonferroni’s tests. 
The datasets for the control loops and non-loops were analyzed with the Wilcoxon matched pairs test 
and paired t-test for apoptosis and proliferation counts, respectively [48]. 
5. Conclusions 
To conclude, the present study shows that pig intestinal explants and loops provide concordant results 
and permit investigating the digestive effects of DON and NIV with a reduced number of animals 
(implementation of the 3Rs). Acute NIV exposure induced mucosal changes at a lower concentration 
than DON in vitro. In vivo, lamina propria cells showed a higher sensitivity than enterocytes to  
NIV-induced apoptosis. Our results demonstrate that NIV toxicity is not similar to DON on the digestive 
target, highlighting the need of a specific hazard characterization for NIV health risk assessment. 
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Abstract 
 
Food and feed safety pose an issue due to mycotoxins, secondary fungal metabolites and usually found as 
mixtures in cereals products. The aim of this work was to analyze the effects of two main mycotoxins, alone 
or associated, deoxynivalenol (DON) and nivalenol (NIV), on the intestinal pig mucosa either after a single 
exposure in vivo, or after repeated exposure of animals. The animals received a natural contaminated feed, 
with DON (2.89 mg.kg-1 feed) or with DON+NIV (3.50 mg.kg-1 /0.72 mg.kg-1 feed) for 28 days. The loops 
model was developed to assess an acute single exposure of DON and NIV individually and in combination 
(1:1) at 1, 3 and 10 µM for 24h. Histological investigations, including morphometry, proliferation and 
apoptosis assessments were conducted. Both experiments were concordant for the total-cell proliferation 
decreased at the villus tips after DON or DON+NIV at 10 µM acutely after 24h, or repeatedly after 28 days, 
by 30-35% and 20-25%, respectively in loops and in animals. In loops model, apoptotic enterocytes at villus 
tips increased dose-dependently by either DON, NIV alone or in combination. The combination in loops at 
10 µM showed higher effects on proliferation and apoptosis than DON alone. The interaction analysis 
showed synergism between DON and NIV for villus apoptotic enterocyte. It is concluded that proliferative 
enterocyte and total-cell proliferation at the villus tips were sensitive to DON and DON+NIV in both models. 
Intestinal loops, in the context of 3Rs, represent a model allowing to investigate the digestive effects of 
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mycotoxins and of food contaminants, and can contribute to improve our knowledge on plausible 
interactions of contaminants present simultaneously at the intestinal level. 
  
Keywords: Apoptosis, Fusarium fungi, intestine mucosa, morphometry, surgical model 
 
1. Introduction 
  
The worldwide contamination of agricultural grain commodities by mycotoxins raise a high 
concern for food and feed safety (Streit et al 2013). Mycotoxins are low-molecular-weight 
secondary metabolites produced by toxigenic fungi (Bouhet and Oswald 2005). 
The Fusarium fungi are commonly found on cereals grown in the temperate regions of 
America, Europe and Asia. They produce mycotoxins, Fusarium toxins, including deoxynivalenol 
(DON) and nivalenol (NIV). F. graminearum and F. culmorum on wheat are both co-producers of 
DON and NIV (Logrieco et al 2002; Bottalico and Perrone 2002). These toxins cause a variety of 
toxic effects in both animals and human (Creppy 2002). DON may have adverse health effects after 
acute or chronic administration. After acute administration of high dose, DON produces mainly 
decrease in feed consumption (anorexia) and emesis (vomiting) of neurogenic origin (Gaigé et al 
2013). The repeated ingestion of low dose of mycotoxins in pig alters the intestine (induces tissue 
lesions, modulate the immune cell count as well as the cytokine synthesis and decreases the 
expression of proteins involved in cell adhesion). Thus it may predispose animals to infections by 
enteric pathogens (Bracarense et al 2012; Pinton et al 2009). DON is capable to disrupt 
proliferation, to induce programmed cell death and to alter genes expression (Petska 2010). Pig is 
the most sensitive species to DON and to NIV toxicity (Pestka and Smolinski 2005; EC 2000). 
Because of its digestive physiology is very similar to that of human (Kararli 1995), pig can be 
regarded as the most relevant animal model for extrapolating to human (Rotter et al 1996). 
NIV health damage is regarded as a serious problem. NIV is considered to be one of the 
mycotoxins needing regulation (SCOOP EU 2003; EFSA 2013). However, the occurrence of NIV 
contamination is limited to some parts of Europe and Asia. Consequently, NIV has been poorly 
studied, and the risks have not been evaluated (EFSA 2013). In vitro, NIV inhibited proliferation of 
human lymphocytes (Thuvander et al 1999). In young male pigs fed with 2.5 or 5 mg purified 
NIV/kg feed for 3 weeks, there was no sign of altered feed intake or body weight and no vomiting 
or clinical problem (Hedman et al 1997b). The rate of absorption of NIV in pig was 11-43% during 
7.5 hours after feeding with 0.05 mg NIV/kg bw twice daily (Hedman et al 1997a). 
Globally, mycotoxin co-occurrence is common (Schatzmayr and Streit 2013), particularly in 
finished feed: for example 58% of which 4548 samples contained two or more mycotoxins (Streit et 
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al 2013). DON and NIV usually co-occur in grains and grain products, and the DON concentration 
is generally higher than that of NIV (Yazar and Omurtag 2008; Schothorst and van Egmond 2004). 
DON and NIV were detected in 57% (n=11022) and 16% (n=4166), respectively, in food samples 
in the European Union (Schothorst and van Egmond 2004). The combination of NIV with DON, T-
2 toxin, or DAS resulted in an additive effect in vitro on human lymphocytes (Thuvander et al 
1999). Interaction between DON and NIV were synergistic in vitro Caco-2 cells (Alassane-Kpembi 
et al 2013). Less additive effect was observed in ex vivo explant (data not published). 
Most researches have been targeted on gastrointestinal tract because it is the first organ 
exposed to food/feed contaminants or xenobiotics (Haschek et al 2010). The gastrointestinal tract 
plays multi-function roles in regulation, storage, propulsion, digestion, absorption, secretion, barrier 
activity and elimination (Pinton and Oswald 2014; Gelberg 2012; Haschek et al 2010). In the 
approach of “3Rs”-Replacement, Reduction and Refinement (Russell and Burch 1959), an 
alternative experimental model will be needed. Many biological models have been used in toxicity 
study such as in vitro (cell culture; Pinton et al 2009) and ex vivo (explants; Kolf-Clauw et al 2009) 
in parallel to conventional animal experiments (Hedman et al. 1997a & 1997b). The intestinal loops 
model has been developed previously in parasitology or in bacteriology studies (Gerdts et al 2001; 
Pernthaner et al 1996; Vandenbroucke et al 2011). Jejunal loops model is an in vivo model allowing 
to analyze the in situ effects of toxics on intestinal mucosa (Cheat et al 2015). 
In our previous study, the digestive effects of DON and NIV were investigated in explants 
and in loops after 4-h exposure, and we identified villus apoptosis and proliferation as sensitive 
endpoints (Cheat et al 2015). In the present study, we investigated these endpoints to compare the 
digestive effects of DON and NIV alone or associated, after a single 24-h exposure in loops, or after 
28-day repeated exposure of animals. 
 
2. Materials and methods 
 
2.2. Purified toxins 
 
DON was acquired from Sigma (St Quentin Fallavier, France) and NIV from Waco Pure 
Chemical Industries LTD (Osaka, Japan). Stock solutions of these mycotoxins were dissolved in 
dimethyl sulfoxide (DMSO) at the 30 mM DON and NIV for the loops experiments. These stock 
solutions were stored at -20 °C. Working dilutions were prepared in physiological saline solution. 
The concentrations at 0 (Ctrl), 1, 3 and 10 µM were used for the dose-response of individual or 
combined mycotoxins. 
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2.2. Animals and toxins exposure 
 
2.2.1. Loops 
For the loops experiment, two 2-month-old Large White female pigs weighting 20 and 25 kg 
were used and housed in the animal facility at INRA Nouzilly. The experimental procedures were 
conducted in accordance with European Guidelines for the Care and Use of Animals for Research 
Purposes and were approved by the Val de Loire local ethical committees for animal 
experimentation (C2EA-06). The animals were fasted for 6h before loops surgery. A 2-m long 
segment of jejunum was surgically prepared, to constitute the loops as previously described (Girard-
Misguich et al 2011; Meurens 2009). This segment was then subdivided into consecutive segments, 
designated as “loops” (10 cm long, 12 loops), separated by “inter-loops”. Treatments, control (Ctrl), 
DON and NIV at 1 µM, 3 µM and 10 µM and DON+NIV (1:1) at 1 µM, 3 µM and10 µM 
concentration were used for each of the 2 pigs (1 loops/pig for each condition) by injecting 3 mL of 
each test condition into each loop. After surgery (24 h), the pigs were intravenously (IV) euthanized 
by barbiturate overdose and the jejunum loop were collected. These loops were washed twice with 
physiological serum prior to fixation in 10% formalin. In addition, jejunum normal segments (nL) 
were sampled and processed in parallel. 
 
2.2.2. Animal experiment 
For the animal experiment, 24-crossbred castrated-male piglets (4-week old) with a mean 
weight of 11.2 (SD 1.2) kg were used. Pigs were acclimatized for 1 week in the animal facility of 
the Toxalim laboratory, INRA (Toulouse, France) before the experimental protocols. They were 
randomly allocated to 4 experimental batch pens with equal numbers. The experimental procedures 
were conducted in accordance with European Guidelines for the Care and Use of Animals for 
Research Purposes and were approved by the INRA local ethical committees for animal 
experimentation (Directive 63/2010/EEC). 
DON and NIV were obtained from a natural contaminated feed source. The levels of the 
other mycotoxins were below the detection limits or considered as negligible (Table A1.). A diet 
without toxins (Ctrl) or with natural single contamination (DON) at 2.89 mg DON/kg feed or co-
contamination (DON+NIV) at 3.50 mg DON/kg with 0.72 mg NIV/kg feed were used to expose 
orally the animals for 28 days. Feed and water were provided ad libitum throughout the 
experimental period. The feed composition is given (Table A1.). 
Body weights were measured before starting the experiment (day 0). The body weights and 
feed intake were measured weekly and at the end of the experiment period (day 28). The blood 
samples were collected at days 0, 7 and at 28 for biochemistry analysis: total serum protein (TP), 
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albumin, fibrinogen, gamma-glutamyl transferase (GGT). At the end of the experiment, the pigs 
were fasted overnight prior to be subjected to electrical stunning and euthanized by exsanguination. 
The jejunum segments were immediately collected and processed as the “Swiss rolls” (Moolenbeek 
and Ruitenberg 1981), then fixed in 10% buffered formalin solution for histological procedure. 
 
2.3. Histological assessment 
 
2.3.1. Histological processing and architectural changes 
A routine histological processing sequence was used. Paraffin sections from the loops and 
from the animal experiment, 4-µm thick were stained with HE to assess architectural changes and 
immunohistochemically labeled (IHC) to assess proliferation and apoptosis. 
Eclipse E400 Nikon microscope, with DS-FI camera driven by NIS-D element software 
(Nikon) was used to capture images (x100 magnification) and take the examinations for 
architectural evaluation of the digestive mucosa. Approximately 30 well-oriented villi and crypts 
per loop were selected on each section to measure villus height and crypt depth. A villus was 
measured from the tip to the shoulder (crypt-villus junction) and a crypt was measured from the 
shoulder to its base, as described previously (Cheat et al 2015). The index was calculated as 
described previously (Cheat et al 2015). The crypt-depth to villus-height ratio was calculated to 
assess the intestinal architectural changes after the treatment (Haschek et al 2010). 
 
2.3.2. Immunohistochemistry 
Briefly, four-micrometer paraffin-embedded transverse sections from formalin-fixed 
jejunum specimens were dewaxed in toluene and rehydrated by an acetone bath then deionized 
water. Antigen retrieval was performed in 10 mM citrate buffer pH 6.0 for 30 min in a water bath at 
95°C. Cooled sections were then incubated in Dako peroxidase blocking solution (Dako S2023) to 
quench endogenous peroxidase activity. Non-specific binding was blocked by incubation in normal 
goat serum (dilution 1:10, Dako X0902) for 20 min at room temperature. Two commercial 
antibodies were used as previously described (Abot et al 2013; Laprie et al 1998). The primary 
antibodies were anti-Ki-67antigen (Dako M7240, dilution 1:50) and anti-active caspase-3 (R&D 
system, AF835, dilution 1:300). Sections were incubated with primary antibodies for 50 min at 
room temperature (RT). Bound primary antibodies were detected with EnVision™ + Horse Radish 
Peroxydase (HRP) Systems (Dako, K4061) 30 min at RT. Peroxidase activity was revealed by 3, 
3’-diaminobenzidine tetrahydrochloride substrate (DAKO, K3468). Finally, sections were 
counterstained with Harris hematoxylin, dehydrated and coverslipped. 
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Proliferative and apoptotic cells were counted after immunohistochemistry in several sites 
on the mucosa. A minimum of 20 well-oriented villi and crypt units were assessed on scanned 
marked slides (Panoramic 250 Flash II – 3D Histech), and analyzed with Pannoramic Viewer 
software (v. 1.15.2) as previously described (Cheat et al 2015). The counts were performed at villus 
tip and crypt basis. Proliferative and apoptotic cells were counted in the upper one-third of the villi, 
i.e. villus tip (positive-total cells: lamina propria plus epithelial cells or enterocyte only). 
Proliferative enterocytes were also counted in the bottom two-thirds of the crypts from the basis. 
The proliferative index of crypt enterocytes was calculated by dividing the number of positive 
enterocytes by the total number of enterocytes (x100) in the crypt bases. The ratios were calculated 
by dividing the number of proliferative cells by the number of apoptotic cells, for enterocytes or 
total cell (lamina propria and epithelial cells). 
 
2.3.3. Interaction analysis of the mycotoxins 
Median-effect doses and combination index (CI) were determined by the Chou-Talalay 
median-effect equation (Chou and Talalay 1984) as previously described in Kolf-Clauw et al 
(2013). Briefly, the median-effect plot of Chou was applied to the individual toxins, and a median-
enterocyte-apoptosis dose (Dm) was calculated for each toxin (CompuSyn Software 2007). For the 
mixture of DON and NIV, the Dm for the mixture was calculated. The CI was calculated for a 10, 
20 and 30 % increase of cell apoptosis. 
 
2.4. Statistical analysis 
 
The Completely randomized and the randomized blocks designs were used in the animal 
experiment and in the loop experimental model, respectively. The result s are presented as means ± 
SD. Plots of fits versus residuals followed by Levene’s and Bartlett’s test, and normal plots of the 
residuals by Anderson-Darling’s test were carried out to confirm the assumptions of homogeneity 
of variances and the normal distribution of residuals, respectively. If these assumptions did not 
hold, the data were normalized and homogenized by log10 or square root prior to analysis to them 
being analyzed. If none of the transformations resolve these problems, then Kruskal-Wallis test was 
used. All tests were performed using the MINITAB package software (V.13.0, Minitab Inc., State 
College, PA, USA). The data were analyzed by applying the GLM option of ANOVA. The datasets 
of control loops and normal segments were analyzed with Wilcoxon matched pairs test and paired t-
test. When there was a significant difference at P-value ≤0.05, then the all pairwise comparisons of 
means were generated by Tukey’s or Behrens Fisher tests and Asymptotic Mann-Whitney tests 
(Bate and Clark 2014; Festing et al 2002). 
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3. Results 
 
3.1. Loops model 
 
The loop results were obtained from 2 pigs after 24 h in situ incubation. 
 
3.1.1. Comparison of loops segments with normal segments 
The morphometry was affected by the surgery in the loop (Table 1.). After surgery, the villi 
of the control loops were shorter and the crypts were deeper compared to normal segments. The 
ratio of crypt-depth to villus-height was significantly higher in control loops than in normal 
segments. The number of proliferative total cells or enterocytes at villus tip, the crypt index of 
proliferative enterocyte, the number of apoptotic cells at villus tip, and the ratio total-cell 
proliferation to total-cell apoptosis at villus tip did not differ between the surgical loop condition 
and normal segments. 
 
3.1.2. Effect of the single mycotoxins on proliferation and apoptosis in loops 
 
a. Effect of DON 
DON induced a bell-shaped curve for the total number of proliferative cells at the villus tip. 
The two lowest concentrations, 1 and 3 µM DON increased the total proliferation by about 20% 
compared to the control loops (Fig. 1A-I), whereas 10-µM DON strongly reduced by about 35% the 
villus total-cell proliferation compared to control loops. 
Villus enterocyte proliferation was not affected at 1 or 10 µM but only at 3 µM was 
observed a slight decrease compared to the control loops (Fig. 1B-I). Villus total cell apoptosis did 
not show clear evidence of DON related effect (data not shown), while the number of apoptotic 
enterocytes at the villus tip increased dose-dependently, with a 20% increase at the highest DON 
concentration (Fig. 1C-I). 
The total-cell proliferation to total-cell apoptosis ratio showed a bell-shaped curve. The ratio 
was about twofold significantly lower at 10-µM DON compared to control loops and about two-to-
threefold higher at 1 and 3 µM compared to control loops (Fig. 1D-I). 
 
b. Effect of NIV 
A similar dose-response tendency to that of DON was observed for the total number of 
villus proliferative cells, with a 40% decrease of total-cell proliferation at 10-µM NIV compared to 
 94 
control loops (Fig. 1A-II). The enterocyte proliferation was not affected at any concentrations (Fig. 
1B-II). 
Enterocyte apoptosis at the villus tips significantly increase in loops at 3 µM and 10 µM 
(Fig. 1C-II). At these concentrations, 3 µM and 10 µM, the ratio of enterocyte proliferation to 
enterocyte apoptosis decreased by about 30% (Fig. 1F-II). The total-cell proliferation to total-cell 
apoptosis ratio showed a bell-shaped curve, as for DON, with a twofold decrease at 10 µM DON, 
compared to control loops (Fig. 1D-II). 
 
3.1.3. Effect of the mixture DON+NIV (1:1) on proliferation and apoptosis in loops 
Similar dose-response curves were observed with the binary combination, compared to 
single mycotoxins. For total-cell proliferation at villus tips, a bell-shaped curve similar to that of 
DON was observed, with an about 30% increase with the lowest doses, and an about 35% decrease 
of the total-cells proliferation at 10-µM DON+NIV (Fig. 1A-III). A dose-dependent relationship 
was found for the increase in enterocyte proliferation at villus tips, with 33% and 15% increase of 
enterocyte proliferation compared to control loops, at 10 and 3 µM respectively (Fig. 1B-III). 
DON+NIV increased dose-dependently enterocyte apoptosis at the villus tips at different 
concentrations (P<0.001). DON+NIV (10 µM) increased the enterocyte apoptosis by 68% 
compared with control loops (Fig. 1C-III). 
Villus enterocyte proliferation to villus enterocyte apoptosis ratio was significantly 
decreased for treated loops reaching 30% compared to control loops, at all concentrations of the 
mixture (Fig. 1F-III). 
 
3.1.4. Comparative effect of DON+NIV (1:1) in loops at 10 µM showed higher effects on 
proliferation and apoptosis than DON alone (Table B2.) 
Enterocyte proliferation at the villus tips was significantly increased by 33% for DON+NIV 
treated loops compared to control loops (Fig. 2A). The effect of DON+NIV was also found at crypt 
levels (Fig. 2B), where DON+NIV exposed loops decreased crypt cell proliferation by 12 %. 
A significant increase was observed in the villus enterocyte apoptosis for DON and 
DON+NIV loops by 21% and 68% (Fig. 2C), respectively, compared with control loops (P<0,001). 
DON+NIV loops increased total-cell apoptosis at the villus tips by about 10% compared with DON 
loops and controls. 
 
3.1.5. Interaction analysis of DON+NIV (1:1) for villus enterocyte apoptosis 
The effect between DON and NIV was synergist for villus enterocyte apoptosis (Fig. 3) with 
CI<1 for an effect below 70% of the control values. 
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3.2. Animal experiment 
 
3.2.1. Zootechnical and clinical pathology: effect of DON and DON+NIV 
In this animal experiment, DON and DON+NIV natural contamination at 2.89 mg DON/kg 
feed and 3.50 mg DON+0.72mg NIV/kg feed did not affect weight gain, feed intake (Table A2.), 
blood total protein, gamma-glutamyl transferase (GGT), albumin and fibrinogen (Table A3.). 
 
3.2.2. Morphometry, proliferation and apoptosis: effect of DON and DON+NIV (Table A4.) 
Dietary exposure to co-contamination DON+NIV significantly increased crypt depth by 
about 5% compared to DON and to control animals (Fig. 4A). 
DON+NIV exposed animals showed a 10-20% decreased in villus enterocyte proliferation 
compared to control animals (Fig. 4B). DON+NIV and DON exposed animals showed 20-25% 
decrease in the number of total proliferating cells at villus tips (Fig. 4C).  
 
4. Discussion  
 
4.1. Models 
 
A conventional experimental animal model (animal experiment) was used to confirm 
endpoints described with loops model. The animal experiment allows to expose the animals to 
natural contaminated feed repeatedly (28-day study). Loops model is the alternative model that 
enables to reduce the number of animals in toxicology study. The interest of the loops model is that 
it has tremendous advantages compared with the models using individual pigs because one pig can 
provide approximately 30 individual loops (Girard-Misguich et al 2011; Boyen et al 2009; Meurens 
2009) and allows multiple doses assessment. The intestinal loop model has been used in several 
species to explore the responses of the intestinal epithelial cells i.e. using bacteria in pigs 
(Vandenbroucke et al 2011; Boyen et al 2009), using bacteria in pigs and bovines (Bolton et al 
1999), using nematode parasites in sheep (Pernthaner et al 1996), studying mucosal immune 
responses in sheep (Gerdts et al 2001). In our study, 24-h in situ incubation was used according to 
our research objective. Besides, this model allows the in situ incubation to be maintained for longer 
durations for example two weeks (Girard-Misguich et al 2011) or four weeks (Gerdts et al 2001) 
without macroscopic lesions or alteration of blood flow. 
However, the limitations of the loop model may be the preservation of normal metabolism 
for morphological preservation and structural integrity on one side. In this model, the comparison 
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between non-loop segment (nL) and control loops (Ctrl) for the tissue architecture such as villus 
height, crypt depth as well as crypt-depth to villus-height ratio revealed a change made by surgery. 
It is the first time, at our knowledge, that these changes are reported and we also previously 
reported vascular changes after 4-h exposure (Cheat et al 2015). A marked atrophy of the villi at the 
vicinity of ulcerative lesions has been reported in villosity architecture of infected and not infected 
jejunal loops (Girard-Misguich et al 2011). On another side, the concentration reaching the targets 
cell might be modulated potential by loops-to-loops transfer, and it is not possible to have neither 
repeated exposure nor natural-occurred mycotoxins treatment via feeding. 
 
4.2. Exposure level and endpoints 
 
The selected concentration ranging from 1 to 10 µM DON was related to previous studies 
(Bracarense et al 2012; Pinton et al. 2012; Marzocco et al 2009), and to realistic concentrations for 
the consumer via food. Each mycotoxin showed significant effects at 10 µM. This latter 
concentration corresponds to an exposure to 3 mg DON/kg contaminated feed or food, assuming 
that DON diluted in one liter of gastrointestinal fluid is ingested in one meal and is 100% 
bioavailable (Sergent et al 2006). The jejunum was chosen to prepare the loops, because it was 
easier than with duodenum or ileum (Girard-Misguich et al 2011). In animal experiment, jejunum 
was chosen because of previous experiments in vivo and ex vivo on this segment (Pinton et al 2009, 
2012; Kolf-Clauw et al 2013) and because of its anatomy and physiology (Haschek et al 2010). The 
discussions will be focused on the highest dose (10 µM) of each toxin. 
In animal experiment, the exposure of natural contaminated DON and DON+NIV at 2.89 
mg DON/kg feed and 3.50 mg DON+0.72mg NIV/kg feed did not induce any change in the 
zootechnical and pathological endpoints studied. The results of clinical pathology were in parallel to 
those of Alizadeh et al. (2015). Effects on the weight gain and feed intake has been shown in 
previous studies from 2 mg/kg feed for four weeks (Gerez et al 2015; Bracarense et al 2012; Pinton 
et al 2012). It is reported that DON is able to decrease nutrient absorption (Ghareeb et al 2015). In 
growing pig exposed to 0.9 mg DON/kg feed for 10 days, weight gain was negatively affected but 
not feed intake (Alizadeh et al 2015). So, in the present study, jejunum mucosa was exposed to 
subclinical level of toxins. Proliferation and apoptosis were chosen as potential sensitive endpoints, 
used in parallel to the loops model, to investigate, in absence of zootechnical effects, the 
consequences of the toxins in situ on the jejunum mucosa. 
Proliferation and apoptosis at different sites of the villi or crypts were selected because there 
was no modification between non-loops and control loops segment for theses endpoints. 
Trichothecenes are well known to act on highly proliferative cells (Pestka 2010), and the intestinal 
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epithelium has been identified as a target for DON and other derivatives in vitro, ex vivo, and in 
vivo (Pinton and Oswald 2014; Kolf-Clauw et al 2013). So, these two endpoints, proliferation and 
apoptosis, are specially relevant to assess the in situ mucosa changes, specifically affected in vitro 
and in vivo by the trichothecenes (Gerez et al 2015; Bianco et al 2012; Bracarense et al 2012; Pinton 
et al 2012; Marzocco et al 2009). 
 
4.3. Effect of DON, NIV and DON+NIV on morphometry 
 
In animal model, crypt depth was increased after DON+NIV exposure but not after DON 
exposure. Jejunal crypts were shown deeper after 3 mg/kg DON feeding for 10 weeks (Dänicke et 
al 2012) and after 0.9 mg/kg DON feeding for 10 days (Alizadeh et al 2015). These results contrast 
with previous other results showing shorter crypt depth after 1.5 mg/kg DON feeding (Gerez et al 
2015). No change in crypt depth was observed after repeated exposure to 3 and 6 mg DON/kg feed 
for 5 weeks and to 3.1 mg DON/kg feed for 37 days (Klunker et al 2013; Bracarense et al 2012). 
The change of crypt depth is shown when more enterocytes need to be generated to migrate 
progressively along the side of its villus, particularly toward the tip, caused by mechanical, toxic or 
xenobiotic damages i.e. the case of malabsorptive diarrheas. Thus, the crypts elongate compared to 
healthy crypts, and this morphologic change is suggested to be site-specific of toxicant involved 
(Haschek et al 2010). Each crypt produces 300-400 cells per day from a relatively few stem cells, 
which in turn divide several more times in the lower and middle portion of the crypts. The rate of 
cell proliferation in the crypts with the rate of mature cell loss at the villus tips is coordinated by 
negative feedback mechanisms (Haschek et al 2010). 
 
4.4. Effect of DON, NIV and DON+NIV on proliferation, apoptosis and the ratio 
proliferation/apoptosis 
 
The experimental loops and the experimental animal models provided concordance for the 
total-cell proliferation decrease at the villus tips after exposure to 10 µM DON or DON+NIV (1:1) 
acutely after 24h or repeatedly after 28 days. These results are in accordance with the 
downregulation of total mRNA of proliferative marker Ki-67 in jejunum of piglet fed purified 0.9 
mg DON/kg diet (Alizadeh et al 2015). This confirms that proliferation is a sensitive endpoint for 
the responses to DON or DON+NIV. Proliferative enterocytes were affected by DON+NIV in 
animal experiment. At villus tips, proliferative enterocytes decreased after 28 days. These results 
are in agreement with those of Bracarense et al (2012). However, proliferative enterocytes were 
found increased in loops treated at 10 µM. In loops model, the decrease of villus total-cell 
 98 
proliferation after 24-h exposed to 10-µM DON and 10-µM NIV is concordant with our recently 
findings with the same concentration but 4-h exposure (Cheat et al 2015). In this previous study 
after exposure to DON and NIV, enterocyte proliferation was not affected, showing that lamina 
propria cells were more affected by these individual mycotoxins. When these two mycotoxins are 
mixed (DON+NIV), both villus total-cell proliferation and villus enterocyte proliferation were 
affected. The 24-h response of enterocytes to the toxins might be dependent on the cell renewal 
cycle because these epithelial cells of the small intestine are replaced every 2-4 days in adult and 
takes longer in neonate (Haschek et al 2010). 
In loops, the results showed bell-shaped dose-response curves for proliferation and apoptosis of 
total cells at villus tips and for the ratio proliferation to apoptosis for individual or combined DON 
and NIV. These non-linear of dose-response curves have been described previously for several 
endpoints, for example cell proliferation in human lung fibroblasts and apoptosis in mouse 
lymphocytes (Calabrese and Baldwin 2001). These biological responses could be related to the 
well-known immunomodulation described with DON and the mechanism of protein inhibition of 
NIV (Severino et al 2006). DON is low-dose stimulation and high-dose inhibition of immune 
response corresponding to lymphocytes proliferation. DON is known as ribotoxic stress response, 
where DON binds to ribosomes and inhibits protein synthesis. NIV inhibits peptidyl transferase 
with subsequent inhibition of peptide bond formation by acting on the initial step of protein 
synthesis and elongation-termination step. Therefore, trichothecenes, particularly DON and NIV are 
toxic to tissues with a high cell proliferation rate (Rocha et al 2005). This suggests a direct 
stimulatory response of immune cells and a response that occurred only as overcompensation to 
initial injury. These responses are concordant with the previously described induction of mitogen 
activated protein kinases (MAPKs) or increased reactive oxygen species (ROS) production in T-
cells and B-cells (Krishnaswamy et al 2010; Pestka 2007) 
The high impact on apoptotic enterocytes with 10-µM DON and 10-µM DON+NIV in loops 
might be due to the impaired antioxidant status of cell and increased production of ROS, 
particularly induced by DON. It has been observed previously in in vitro studies with intestinal 
epithelial cells (Pestka 2007). The effect of DON and NIV on proliferation and apoptosis in the 
intestine, also described in other species (Payros, personal communication), are confirmed in our in 
vivo study with DON and NIV. So, human intestine should be similarly affected. The apoptotic 
enterocytes observed in loops showed similarities with several other human intestinal diseases for 
example microvillus inclusion disease and coeliac disease (Groisman et al 2000; Moss et al 1996). 
 
4.5. Effect of DON on gene expression in vivo 
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In the present study in loops, we did not observe any differences after 24 h in cytokine genes 
expression for IL-1α, IL-1β, IL-6, IL-8, IL-21, IL12-p40, TGF-β (data not shown). Our negative 
results on cytokines from acute 24-h exposure might be due to the time needed for the response 
observed after repeated exposure: for example IL-1β expression was increased in duodenum of 
piglets fed a DON diet (0.9 mg/kg feed) for 10 days, IL-1β and IL-6 expression were up-regulated 
in jejunum of piglets fed a DON diet (3 mg/kg feed) for 35 weeks, or IL-8 expression were up-
regulated in ileum of piglets fed a DON diet (3.5 mg/kg feed) for 42 days (Alizadeh et al 2015; 
Lessard et al 2015; Bracarense et al 2012). 
 However the present result, tight junction protein expression for claudin-4, one important 
component of tight junction protein, was not altered (data not shown). DON exposure, through the 
activation mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase/AKT (protein 
kinase B) signaling pathways, is capable to modulate inflammatory response and to influence the 
expression of tight junction proteins (Mishra et al 2014; Pinton et al 2009). In the similar exposed 
time (24h) in vitro, claudin-4 was up-regulated in Caco-2 cells exposed to increasing concentrations 
(1.39, 4.17, and 12.5 µM) of DON (Akbari et al 2014), whereas DON inhibits the expression of 
claudin-4 in IPEC-1 (Pinton et al 2009). The first hypothesis for addressing this difference between 
the in vitro and our in vivo loop result is the fact that the samples taken in the in vivo loop contained 
the entire intestinal wall, not only the epithelial cell layer. Another hypothesis could be the contact 
time of DON in loops too limited compared to in vitro studies. 
 
4.6. Interaction analysis 
 
In vitro, exposure of intestinal and non-intestinal cells to the trichothecenes alone or in 
combination decreased proliferation (Alassane-Kpembi, et al 2013; Wan et al 2013; Pinton et al 
2012; Petska 2010, Thuvander et al 1999). Concordantly, a decrease was observed in enterocyte 
proliferation to enterocyte apoptosis ratio in loops after 10-µM DON+NIV. Alassane-Kpembi, et al 
(2013) found that NIV and DON+NIV were more toxic than DON alone in Caco-2 cells. The 
present study shows a similar type of interaction between DON and NIV on a different target. The 
interaction analysis confirmed synergism between the two mycotoxins for villus enterocyte 
apoptosis. Our results are of high relevance, because they were obtained in models (animals or 
loops) more complex than the cell lines. A recent study on the pig intestinal cell line IEC-6 
suggested also a more than additive interaction between DON and NIV based on their pro-oxidant 
effect (Del Regno et al 2015). 
 
Conclusion 
 100 
 
The current study showed that proliferative enterocyte and total-cell proliferation at the 
villus tips were sensitive to DON and DON+NIV in both models. The loops allowed testing the 
interaction between the two mycotoxins, DON and NIV. Taking together from the previous study 
(Cheat et al. 2015), our data indicate that intestinal loops model, in the context of 3Rs, represents a 
relevant and sensitive model to investigate the digestive effects of food contaminants. Limitations to 
unique exposure and to non-natural occurring mycotoxin treatments are its main disadvantages. 
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Table and figure legends 
 
Table 1. Comparison of control loops and non-loops segments for surgical effect after 24h post-surgery on 
morphometry, proliferation-cell and apoptosis-cell counts of the jejunum. 
 
Figure 1. Proliferation and apoptosis in the jejunum loops after exposed to DON (I), NIV (II) and 
DON+NIV (1:1) (III) at 1, 3 and 10 µM for 24h. Mean values ± SD expressed as % of the control group 
(Ctrl). (A-I, A-II, A-III)  Total-cell proliferation at villus tip (upper one-third); (B-I, B-II, B-III) Villus 
enterocyte proliferation; (C-I, C-II, C-III) Villus enterocytes apoptosis; (D-I, D-II, D-III) Total-cell 
proliferation to total-cell apoptosis ratio at villus tip; (E-I, E-II, E-III) Villus total-cell apoptosis; and (F-I, F-
II, F-III) Villus enterocyte proliferation to apoptosis ratio. Letter a, b and c are different at P≤0.05; Behrens 
Fisher tests and Asymptotic Mann-Whitney tests; n = 2 or 4 (Ctrl) loops, 20 villi or crypts/loop. 
 
Figure 2. Combined effect of the mixture of DON and NIV (1:1) in loops at 10 µM showed higher effects on 
proliferation and apoptosis than DON alone. Mean values ± SD expressed as % of the control group (Ctrl). 
(A)  Enterocyte proliferation at villus tip (upper one-third), P<0.001; (B) Enterocytes proliferation at crypt 
base (lower two-third), P=0.001; and (C) Villus enterocyte apoptosis, P<0.001. Letter a, b and c are different 
at P≤0.05; Tukey’s test or Behrens Fisher tests and Asymptotic Mann-Whitney tests; n = 2 or 4 (Ctrl) loops, 
20 villi or crypts/loop. 
 
Figure 3.  Isobolograms illustrating the combined effect of the mixture of DON and NIV (1:1) for reaching 
10% (Fa = 0.1, circle), 20 % (Fa = 0.2, square), or 30 % increase (Fa = 0.3, triangle) of villus enterocyte 
apoptosis in jejunal loops model. The points on each axis are mean concentrations of dose– response curves 
of each toxin alone (CompuSyn® software analysis). 
 
Figure 4. Jejunal morphology, proliferation and apoptosis in in vivo animal after exposed to DON natural 
single- at 2.89 mg.kg-1 feed and co-contamination to DON+NIV at 3.50 mg.kg-1 feed. Mean values ± SD 
expressed as % of the control group (Ctrl). (A) Crypt depth, P=0.007; (B) Enterocyte proliferation at villus 
tip (upper one-third), P<0.001 and (C) Total cell proliferation at villus tip, P=0.009. 
 
 
 
 
 
 
 
 107 
 
 
Table 1. 
Comparison of control loops (Ctrl) and non-loops segments (nL) for surgical effect after 24h 
post-surgery on morphometry, proliferation-cell and apoptosis-cell counts of the jejunum 
Parameters nL Ctrl P-value 
Morphometry    
Villus height (µm) 378.1 ±63.8 339.6 ±64.5 0.014** 
Crypt depth (µm) 336.2 ±40.9 364.6 ±50.7 0.007** 
Crypt-depth to villus-height ratio 0.90 ±0.20 1.11 ±0.28 <0.001*** 
Proliferation     
Villus total cell 33.08 ±6.17 35.23 ±4.86 0.127w 
Crypt index (x100) 66.6 ±9.8 64.8 ±10.4 0.453 w 
Apoptosis    
Villus total cell 3.55 ±0.90 3.54 ±0.97 0.976 
Ratio    
Total-cell proliferation to total-cell apoptosis 9.84 ±4.67 10.70 ±7.93 0.216 
- Data presented as mean ± standard deviation (SD);Paired t-test 
- 
w
 = Wilcoxon matched pairs test 
- 
**
 : Significant level P≤0.01; *** : Significant level P≤0.001  
- Morphometry: n= 2 or 4 (Ctrl) loops, 30 villi or crypt /loop; Values are mean numbers per 
villus or per crypt 
- Proliferation and apoptosis: n= 2 or 4 (Ctrl) loops, 20 villi or crypt/loop; Values are mean 
numbers per1/3 villus tip or per 2/3 crypt base 
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Figure 1. Proliferation and apoptosis in the jejunal loops after exposed to DON (I), NIV (II) and 
DON+NIV (1:1) (III) at 1, 3 and 10 µM for 24h. Mean values ± SD expressed as % of the control 
group (Ctrl). (A-I, A-II, A-III) Total-cell proliferation at villus tip (upper one-third); (B-I, B-II, B-III) 
Villus enterocyte proliferation; (C-I, C-II, C-III) Villus enterocytes apoptosis; (D-I, D-II, D-III) Total-
cell proliferation to total-cell apoptosis ratio at villus tip; (E-I, E-II, E-III) Villus total-cell apoptosis; 
and (F-I, F-II, F-III) Villus enterocyte proliferation to apoptosis ratio. Letter a, b and c are different at 
P≤0.05; Behrens Fisher tests and Asymptotic Mann-Whitney tests; n = 2 or 4 (Ctrl) loops, 20 villi or 
crypts/loop. 
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Figure 2. Combined effect of DON and NIV (1:1) 
in loops at 10 µM showed higher effects on 
proliferation and apoptosis than DON alone. Mean 
values ± SD expressed as % of the control group 
(Ctrl). (A)  Enterocyte proliferation at villus tip 
(upper one-third), P<0.001; (B) Enterocytes 
proliferation at crypt base (lower two-third), 
P=0.001; and (C) Villus enterocyte apoptosis, 
P<0.001. Letter a, b and c are different at P≤0.05; 
Tukey’s test or Behrens Fisher tests and 
Asymptotic Mann-Whitney tests; n = 2 or 4 (Ctrl) 
loops, 20 villi or crypts/loop. 
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Figure 3.  Isobolograms illustrating the combined effect of the 
mixture of DON and NIV (1:1) for reaching 10% (Fa = 0.1, 
circle), 20 % (Fa = 0.2, square), or 30 % increase (Fa = 0.3, 
triangle) of villus enterocyte apoptosis in jejunal loops model. 
The points on each axis are mean concentrations of dose-
response curves of each toxin alone (CompuSyn®) 
 
 
 
 
 
 
 
 
 
 
 
2.5 
NIV (µM) 
 
D
O
N
 
(µ
M
) 
 111 
  
  
Figure 4. Jejunal architecture, proliferation and apoptosis in in vivo animal after exposed to DON 
(2.89 mg.kg-1 feed) natural single- and co-contamination to DON+NIV (3.50 + 0.72 mg.kg-1 feed). 
Mean values ± SD expressed as % of the control group (Ctrl). (A) Crypt depth, P=0.007; (B) 
Enterocyte proliferation at villus tip (upper one-third), P<0.001; (C) Total cell proliferation at villus 
tips, P=0.009.; and (D) Crypt-depth to villus-height ratio, P<0.001. 
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3.3. General discussion 
 
3.3.1. Benefits and limitations of the alternative models 
  
Biological models can be used in toxicology studies such as in vitro, cell culture (Pinton et al. 
2009); ex vivo, explants, (Kolf-Clauw et al. 2009) and in vivo, animal experiment (Claude 1957; 
Hedman et al. 1997). Among those models, in vivo is costly, time consuming and limited by 
individual variations. In this work, we use conventional animal experiment (in vivo), but also 
alternative models either in vivo (loops) or ex vivo (explants). These models allow to reduce the 
number of animals used in agreement with the 3Rs recommendation of Russel and Burch (1959). 
However, the in vivo model provides a complete animal biological response to the treatments. Loop 
is an in vivo model the created loops being in situ maintained inside the pigs. This model has been 
used in bacterial infection studies on different animal species (Girard-Misguich et al. 2011; 
Vandenbroucke et al. 2011; Gerdts et al. 2001; Bolton et al. 1999; Pernthaner et al. 1996). To the 
best of our knowledge, to date, the use of this model is neglected in toxicologic studies. The 
discussions below are related to the concordant results obtained from the three types of model. 
 
3.3.2. In animal experiment 
 
Feed intake and weight gain have been found to be depressed in several studies after repeated 
exposure to DON (Xiao et al. 2013; Pinton et al. 2012; Danicke et al. 2012a; Danicke et al. 2012b). 
However in the present study, DON and DON+NIV, natural contamination at 2.89 mg DON/kg 
feed and 3.50 mg DON+0.72 mg NIV/kg feed did not impact weight gain nor feed intake, and of 
the clinical biochemistries investigated such as blood total protein, gamma-glutamyl transferase 
(GGT), albumin and fibrinogen did not change. The proportion of co-contamination used here in 
animal experiment were similar to that of DON and NIV in the analyzed samples from food 
collected in the European Union (Schothorst and van Egmond 2004). These toxins are of concern 
for human and animal health (EFSA 2013). A similar result for the unchanged-weight gain was 
reported in DON-exposed animals at 1.5 mg.kg-1 diet (Gerez et al. 2015). Our study showed a high 
toleration of the pigs to the levels of mycotoxins used while various studies reported that pig could 
be tolerate up to DON 0.9 mg.kg-1 feed without any adverse effects on feed intake and live weight 
gain (EFSA 2007). 
 
The current study shows that villus height was increased after DON exposure but not after 
DON+NIV exposure in animal experiment. In general assumption, intestinal morphological 
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changes of small intestine, caused by injurious agents such as DON (Diesing et al. 2011), 
xenobiotics (Haschek et al. 2010) are reduction of the villus height because of villus contraction, 
which support the restoration of the barrier function through minimizing the surface area 
(Blikslager et al. 2007). By contrast, the present result is not the case when villi were higher than 
control animals after DON exposure. DON from 1.5-3 mg.kg-1 feed reduction of villus height has 
been previously reported in animal experiments (Gerez et al. 2015, Lucioli et al. 2013, Bracarense 
et al. 2012; Pinton et al. 2012). Our observation could also be incidental, as DON+NIV had no 
effect on villus height in the current study which is not consistent with observations of Gerez et al. 
(2015) using a tertiary combinations of DON+NIV+ZEA. 
 
3.3.3. Proliferation 
 
Trichothecenes have been reported to highly act on proliferative cells, and the intestinal epithelium 
has been identified as a target for DON and other derivatives in vitro, ex vivo, and in vivo (Kolf-
Clauw et al. 2013; Gauthier et al. 2013; Bianco et al. 2012; Bracarense et al. 2011; Pinton et al. 
2012). Although effects have been found for subchronical exposure, the current study, showed 
significant impact, starting from a 3 µM concentration on proliferative enterocytes with combined 
DON and NIV after 24h on loops. 
 
At intestinal epithelium, enterocytes originate from the small intestinal crypts which surround the 
base of each villus. Biologically, these enterocytes progressively move along the side of the villus 
toward the tip, crypt-villus axis. As senescent enterocytes slough from the tip of villi, the absorptive 
epithelium is replaced from below by dividing epithelium cells. Each crypt produces 300-400 cells 
per day from a relatively few stem cells that produce committed daughter cells, which in turn divide 
several more times in the lower and middle portion of the crypts and are replaced every 2-4 days in 
adult, but replacement take longer in the neonate (Haschek et al. 2010; Booth and Potten 2000). 
However, this basic biological phenomenon for tissue homeostasis was effectively induced only 
when the combined DON and NIV were ingested repeatedly. The result of the impact of 
mycotoxins on proliferative enterocytes is in correlation to a concept that intestinal epithelial cells 
are important targets for the toxic effects of mycotoxins resulted only when they are exposed for 
subchronical period (Bouhet et al. 2004). Damage of intestinal epithelium cell can be induced and 
might have consequences for animal and human health exposed to xenobiotics or contaminated 
feed/food (Pinton et al. 2009). 
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Watson (1995) suggested that more studies are required to describe the fate of cells at the villus tip. 
Thus the current studies, at least in part, support this suggestion since the negative feedback 
mechanisms coordinate the rate of cell proliferation in the crypts with the rate of mature cell loss at 
the villus tip (Haschek et al. 2010), although it is not certain if the form of apoptosis is responsible 
for epithelial cell sloughing from the villus tips (Watson 1995). The result of total-cell count, 
assuming that most cells were lymphocytes, DON and DON+NIV inhibited proliferation at 10 µM 
in 24-h loops. In a dose-dependent manner, limited variation was sensitive between individuals or 
combined DON and NIV in 24-h loops and the inhibition was in accordance with Thuvander et al. 
(1999).  
 
3.3.4. Apoptosis 
 
In the small intestinal mucosa, apoptosis has been extensively studied (Groisman et al. 2000). 
However, to the best of our knowledge, it seems to be scarce using this biomarker in 
mycotoxicologic study, particularly for DON and NIV. Apoptosis is defined that cells undergoing 
apoptosis are morphologically characterized by condensation of nuclear chromatin into caps at the 
edge of the nucleus and detachment from their neighbors (Watson 1995). In particular, caspase-
dependent apoptosis plays an executive role in the pathogenesis of a huge number of human 
diseases i.e. autoimmune diseases, multiple types of cancer, (Favaloro et al. 2012), and diseases of 
intestinal tract, for instance microvillous inclusion disease (Groisman et al. 2000; Watson 1995). 
Therefore, quantifying this biomarker will improve our knowledge of the health risk caused by 
mycotoxin. 
 
In this study, apoptotic cells were counted at the villus tips compared to the crypts. Groisman et al. 
(2000) found that apoptotic cells were located in the upper third of villi in the normal small 
intestinal biopsies. Therefore, the upper one-third of villi where the current study assessed is 
corroborative the findings of Groisman et al. (2000) and the descriptions of Haschek et al. (2010) 
and cellular events of Watson (1995). At 24-h acute exposure in loops, individual 10 µM DON and 
starting from 3 µM NIV significantly increased apoptotic enterocyte at the villi, while the 
combination of this two mycotoxins affected even from 1 µM concentration. The lower doses, for 
example in NIV or in the combined DON and NIV, seemed to produce modulations with biological 
activity below the traditional toxicological threshold. Thus, it is assumed that follows a partern of 
hormesis, a dose-response phenomenon characterized by low-dose stimulation and high-dose 
inhibition (Calabrese 2002). It also well known that mycotoxins are immunomodulators for 
gastrointestinal tract (Oswald et al. 2005). A strong impact of the combined mycotoxins in the 
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present study reflects the results from previous reports. Thuvander et al. (1999) found that 
combinations of NIV with DON or T-2 toxin, DAS resulted in an additive effect. Caco-2 cells 
showed a different interaction effect between DON and NIV at in vitro cell level (Alassane-Kpembi 
et al. 2013). As results, the present combination of DON and NIV showed interaction effect on 
enterocytes for apoptosis in 24-h loops, and proliferation from both 24-h loops and animal 
experiment because the effects were greater when these two mycotoxins were combined. 
 
The apoptotic enterocyte increase after 24-h exposed to 10 µM DON and DON+NIV, show 
similarity in microvillus inclusion disease (MID) and coeliac disease. MID is a specific disorder 
causing severe refractory diarrhea with diffuse villus atrophy without inflammatory changes in 
neonates. Coeliac disease is characterized by flat mucosa despite epithelial hyperproliferation in 
human (Groisman et al. 2000; Moss et al. 1996). The lesional changes such as villi atrophy, 
flattening of the epithelial cells found in explant after DON or NIV exposure were similar to those 
disease characteristics. In both cases, Groisman et al. (2000) and Moss et al. (1996) hypothesized 
that increased apoptosis is a major factor in the increased cell loss in MID and coeliac disease even 
if another forms of cell loss are exist. This is apparently shown in the present study. The absolute 
numbers of proliferating cells in the current study surpassed those of apoptotic cells at the villi. 
Thus, proliferative enterocyte to apoptotic enterocyte ratio at the villi was calculated, showing that 
DON+NIV had lower ratio in comparison with control loops and similar in comparison with DON 
treated loops. In loops model, many interleukin inflammatory genes which response to an 
inflammation were quantified by qRT-PCR, expressed no difference in 10-µM DON after 4-h and 
24-h exposure. These results, at least in part, could support the similar characteristics of DON and 
MID affect intestinal health. 
 
Either in 4-h loops or in 24-h loops a biological response for proliferation and apoptosis occurred 
immediately after exposure to DON or NIV. It was clearly shown that enterocyte apoptosis was not 
affected after 4-h exposure to DON or NIV. However, both proliferation and apoptosis of the total-
cell counts were affected, with NIV impacted greater than DON after 4-h exposure. So, our studies 
show that lamina propria cells, mainly lymphocytes are more sensitive than enterocytes. The strong 
impact of NIV is confirmed with Wan et al. (2013) that NIV had the potency greater than DON in 
cell viability. Although, in the current study, these biological responses were not seen after 24-h 
incubation, suggesting that compensating responses might loss at this time because significant 
effects were found from individual, except for dose-dependent NIV and combined mycotoxins on 
the same counts. 
 
 116 
A balance between cell proliferation and cell apoptosis is thought to preserve the normal 
architecture in the small intestine. It is reported that proliferative cells are found in the base of the 
crypts, and apoptotic cells are seen most frequently toward the tips of the villi (Watson 1995; Hall 
et al. 1994). In our study, one hand showed in 4-h loops that apoptotic enterocytes at the villi were 
not different after DON or NIV exposures, although crypt index proliferation was increased by 
NIV. On the other hand, 24-h loops showed that apoptotic enterocytes at the villi were significantly 
increased in DON or DON+NIV treated loops, even though crypt proliferation index was not 
affected at 10-µM exposure. These might be the insufficient time (after 4 h) shown for engulfment 
of apoptotic bodies by adjacent cells that would permit reutilization of the cellular materials. 
 
3.4. General conclusion 
 
In explant, the mucosa changes were induced by NIV at lower concentrations than DON. The total-
cell count, mainly lymphoid cells, showed higher sensitivity than enterocytes to NIV-induced 
apoptosis after 4-h exposure in loops model. In loops model, DON+NIV showed high impact on 
proliferative enterocytes at both villus tip and crypt base after 24-h exposure. It also impacted 
enterocyte apoptosis and total-cell count at villus tip. In animal experiment, DON and DON+NIV 
decreased total-cell count proliferation at the villus tip while only DON+NIV affected enterocyte 
proliferation and significantly elongated the crypt depth. DON or NIV exposure has characteristics, 
at least in part, related to human diseases, microvillus inclusion disease and celiac disease leading to 
impaired nutrient absorption. 
 
NIV alone or in combination with DON induced enterocyte proliferation and enterocyte apoptosis 
at the villi of pig small intestine following acute or repeated exposure. The interaction was shown 
on enterocytes for apoptosis in 24-h loops, and for proliferation in both 24-h loops and animal 
experiment. Thus, enterocytes were found to be a biomarker for the toxin effects for the two 
models, loops and animal experiment. In addition, loops model allowed in situ testing possible for 
dose-response and analyzing the interaction of the mycotoxins, despite the fact that it is not 
convenient to model repeated exposures. Owing to the lack of sufficient toxicological data for most 
of the masked mycotoxins and emerging mycotoxins, the loops model may contribute to risk 
assessments of these toxins. 
 
3.5. Perspectives 
 
 117 
The blood tests for the mycotoxin concentrations will indicate the real internal exposure of the 
animals, and these can verify the absorption, distribution, metabolism and excretion patterns in 
toxicology. The immunomodulation impact from individual or combined of DON and NIV at lower 
concentrations i.e. 1 µM or 3 µM, should be considered. 
 
More efforts will be given to differentiate enterocytes and their migration rate along the villus axis. 
Furthermore, to identify the cells that mainly involved in the mucosa level in response to immune 
response i.e. neutrophils, eosinophils, monocytes, lymphocytes, etc. Then, proliferation and 
apoptosis scenarios, particularly in lamina propria should be considered. 
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Appendixes 
 
A. Animal experiment 
 
Table A1. 
Composition of the experimental diets (%, g.kg-1 or kcal.kg-1 based on a DM content of 88%); 
ARVALISADAESO-ITP 2002 
 Ctrl DON DON+NIV DON+ 
Composition (%)     
Uncontaminated Wheat Galopin 46.95 - 49.08 - 
Contaminated Wheat 17885 ++  13.98  36.45 
Contaminated maize 10-19077 - - 25.00 - 
Contaminated Wheat 17828 - 47.00 - 24.00 
Uncontaminated Corn 18469 25.00 10.00 - 11.00 
Soybean meal 48 21.00 22.00 18.80 21.50 
Lysine HCL 0.57 0.55 0.63 0.56 
L-Threonine 0.25 0.25 0.25 0.25 
DL-Methionine 0.18 0.18 0.18 0.20 
L-Tryptophan 0.05 0.04 0.06 0.04 
Vitamins and minerals premix 4.00 4.00 4.00 4.00 
Soybean oil 2.00 2.00 2.00 2.00 
Nutrients (%DM)     
Dry matter 872.6 882.4 874.0 877.2 
Total nitrogen 171.4 172.5 173.9 171.1 
Crude fiber 23.7 24.2 23.3 23.9 
Starch (Ewers methods) 442.0 435.3 446.4 434.9 
Crude Fat 36.2 32.9 36.6 33.1 
Minerals 59.4 60.7 58.4 60.3 
Calcium 12.8 12.7 12.7 12.8 
Phosphor 6.8 7.0 6.8 7.0 
Digestible Energy 3437 3471 3456 3450 
Net energy 2502 2515 2517 2503 
Net energy (g4) 2494 2507 2507 2494 
Total nitrogen/Net energy (g4) 69 69 69 69 
LysineT 12.5 12.5 12.4 12.5 
LysineD 11.5 11.5 11.5 11.5 
LysineD/Net energy (g4) (g/1000 kcal) 4.6 4.6 4.6 4.6 
MethinoninD/LysinD (%) 37 36 36 38 
Methionine + CysteineD/LysineD 61 60 60 62 
ThreonineD/LysineD 67 67 66 66 
TryptophanD/LysineD 20 20 20 19 
TryptophanD /Neutral amino acid 6 6 6 6 
Mycotoxins (mg.kg-1)     
DON 0.03 2.89 3.5 4.63 
NIV <0.01 0.07 0.72 0.05 
ZEA <0.01 0.01 0.08 0.045 
15-acétyl DON <0.01 0.01 0.19 0.015 
3-acétyl DON <0.01 <0.01 <0.01 <0.01 
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Table A2. 
Effect of DON and DON+NIV after 28-day repeated exposure with DON natural single- at 2.89 
mg.kg-1 feed and co-contamination to DON+NIV at 3.50 mg DON+ 0.72 mg NIV.kg-1 feed on weight 
gain and feed intake 
Parameters Ctrl DON DON+NIV P-value 
Weight gain (kg/pig)     
Average daily gain 0.51 ±0.12 0.57 ±0.10 0.49 ±0.06 0.358 
Day 0 11.02 ±1.43 10.87 ±1.29 11.22 ±1.09 0.893 
Day 7 13.78 ±2.16 13.20 ±1.4 13.20 ±1.55 0.800 
Day 14 16.93 ±2.79 17.30 ±2.39 16.38 ±1.49 0.787 
Day 21 20.95 ±3.32 21.90 ±3.03 20.40 ±1.64 0.644 
Day 28 25.27 ±4.71 26.53 ±3.81 24.75 ±2.16 0.699 
Feed intake (kg/pig)      
Average weekly intake  6.15 ±1.18 6.43 ±1.88 5.72 ±1.52 0.815 
Day 7 4.63 4.12 3.65 N/a 
Day 14 5.80 5.70 5.60 N/a 
Day 21 7.05 7.72 6.47 N/a 
Day 28 7.13 8.17 7.17 N/a 
- Data presented as mean ± standard deviation (SD), ANOVA 
- N/a: not assessable 
- Weight gain or feed intake,  n= 6 pigs 
 
 
Table A3. 
Effect of DON and DON+NIV after 28-day repeated exposure with DON natural single- at 2.89 mg.kg-1 
feed and co-contamination to DON+NIV at 3.50 mg DON+ 0.72 mg NIV.kg-1 feed on blood biochemistry 
Parameters Ctrl DON DON+NIV P-value 
Total protein (g/L)     
Day 0 54.33 ±5.43 48.33 ±1.70 50.82 ±2.05 0.060kw 
Day 28 61.10 ±3.47 63.28 ±4.61 61.00 ±3.08 0.512 
% changed 13.03a ±8.54 30.92b ±8.40 20.16ab ±6.90 0,005 
Albumin (g/L)      
Day 0 29.35 ±3.57 27.53 ±2.71 29.53 ±1.90 0.417 
Day 28 34.87 ±2.60 36.27 ±2.68 34.50 ±1.78 0.422 
% changed 20.28 ±17.95 32.17 ±8.67 17.37 ±11.19 0.155 
Fibrinogen (g/L)     
Day 0 17.28 ±4.37 19.15 ±3.57 20.26 ±1.84 0.408 
Day 7 20.24 ±4.10 23.07 ±2.33 22.80 ±2.62 0.293 
Day 28 23.52 ±3.81 20.62 ±1.25 22.48 ±3.03 0.246 
% changed 38.24 ±11.44 11.52 ±26.83 22.80 ±2.62 0.060 
Gamma-glutamyl transferase (U/L)     
Day 0 82.17a ±32.59 52.83ab ±9.54 47.67b ±14.05 0.020 
Day 28 60.17 ±17.88 69.17 ±21.99 60.50 ±18.87 0.674 
% changed -20.28a ±27.78 29.59b ±24.37 31.27b ±43.26 0.025 
- Data presented as mean ± standard deviation (SD), ANOVA, n=6 pigs 
- 
kw
: P-value from Kruskal-Wallis test 
- 
a, b
 mean values with different superscripts within the same row are different at P≤0.05; Tukey’s test 
 
 
 
 
 
 
 142 
Table A4. 
Effect of DON and DON+NIV after 28-day repeated exposure with DON natural single- at 2.89 
mg.kg-1 feed and co-contamination to DON+NIV at 3.50 mg DON+ 0.72 mg NIV.kg-1 feed on 
morphometry, proliferation-cell and apoptosis-cell counts of the jejunum 
Parameters Ctrl DON DON+NIV P-value 
Morphometry     
Villus height (µm) 419.4a ±95.1 481.3b ±89.9 425.2a ±103.2 <0.001kw 
Crypt depth (µm) 340.4a ±45.4 337.1a ±57.6 354.8b ±60.3 0.007kw 
Crypt-depth to villus-height ratio 0.877a ±0.25 0.742b ±0.23 0.889a ±0.25 <0.001kw 
Proliferation      
Villus total cell 77.80a ±21.31 57.83b ±14.70 62.38b ±16.78 0.009 
Villus enterocytes 50.21a ±17.82 45.06a ±13.36 39.91b ±10.71 <0.001kw 
Lamina propria (cell) 27.59a ±8.68 12.77b ±3.52 22.47a ±6.04 0.002kw 
Apoptosis     
Peyer’s Patches (cell) 35.17a ±9.83 38.93b ±7.71 32.03a ±12.82 0.009kw 
- Data presented as mean ± standard deviation (SD), ANOVA 
- 
kw
 = P-values from Kruskal-Wallis test  
- 
a, b
 mean values with different superscripts within the same row are different at P≤0.05; Tukey’s test 
or Behrens Fisher tests and Asymptotic Mann-Whitney tests  
- Morphometry: n= 6 pigs, 30 villi or crypt /loop; Values are mean numbers per villus or per crypt 
- Proliferation and apoptosis: n= 6 pigs, 20 villi or crypt/loop; Values are mean numbers per1/3 villus 
tip or per 2/3 crypt base 
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B. Loops model 
 
Table B1. 
Gene expressions of jejunal loops treated with 10-µM DON for 4-h in situ incubation. 
Genes Ctrl DON P-value 
IL-1α 1 ±0.872 0.702 ±0.559 0.221 
IL-1β 1 ±0.661 0.584 ±0.257 0.106w 
IL-6 1 ±0.471 0.583 ±0.499 0.276 
IL-8 1 ±0.763 0.838 ±0.599 0.595 
IL-10 1 ±0.486 1.070 ±0.613 0.632 
IL12-p40 1 ±0.914 0.548 ±0.283 0.590w 
IL-21 1 ±0.845 0.980 ±0.603 0.923 
TLR-1 1 ±0.507 1.034 ±0.263 0.784 
TLR-2 1 ±1.710 0.650 ±1.220 0.254 
TLR-5 1 ±0.523 0.719 ±0.185 0.267 
TLR-9 1 ±0.736 0.924 ±0.569 0.606 
CCL-20 1 ±2.110 0.140 ±0.106 0.787w 
NF-κB 1 ±0.551 0.752 ±0.231 0.178 
TNF-α 1 ±0.739 0.782 ±0.281 0.556 
TGF-β 1 ±0.656 1.100 ±0.834 0.845 
IFN-γ 1 ±0.336 1.183 ±0.416 0.205 
ALP 1 ±0.771 0.701 ±0.182 0.281w 
EDN-2 1 ±0.820 0.859 ±0.630 0.646 
Lysozyme 1 ±1.420 0.444 ±0.541 0.229 
PCNA 1 ±0.566 0.744 ±0.197 0.324 
Claudin-1 1 ±0.474 0.838 ±0.366 0.551 
Claudin-2 1 ±1.010 0.582 ±0.341 0.262 
Claudin-3 1 ±0.997 0.990 ±0.988 0.979 
Claudin-4 1 ±0.852 0.613 ±0.300 0.214 
Occludin 1 ±0.250 0.808 ±0.338 0.376 
E-cadherin 1 ±0.823 0.635 ±0.238 0.787w 
ZO-1 1 ±0.267 0.777 ±0.199 0.188 
- Data presented as mean ± standard deviation (SD); n= 5 (pigs); Paired t-test 
- 
w
 = Wilcoxon matched pairs test 
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Table B2. 
DON+NIV (1:1) after 24h exposure at 10µM in loops showed higher effects on proliferation-cell and 
apoptosis-cell counts but not morphometry of the jejunal loops 
Parameters Ctrl DON DON+NIV P-value 
Morphometry     
Villus height (µm) 339.6 ±64.5 325.5 ±55.1 341.0 ±63.5 0.175 
Crypt depth (µm) 364.6 ±50.7 375.2 ±38.3 363.6 ±42.7 0.269 
Crypt-depth to villus-height ratio 1.11 ±0.28 1.14 ±0.21 1.17 ±0.24 0.196 
Proliferation      
Villus total cell 35.23a ±4.86 22.60b ±4.33 22.40b ±4.55 <0.001 
Villus enterocytes 18.39a ±4.47 19.15a ±4.70 24.43b ±4.91 <0.001 
Crypt enterocytes 50.54a ±4.47 50.58a ±4.70 44.53b ±4.91 0.001 
Apoptosis     
Villus enterocyte 2.46a ±0.98 2.98b ±0.80 4.13c ±1.30 <0.001kw 
Lamina propria (cell) 2.38 ±0.93 2.25 ±1.16 2.03 ±0.95 0.290 kw 
Villus total cell 3.54a ±0.97 3.56ab ±0.94 3.96b ±0.92 0.039 kw 
Ratio     
Enterocyte  proliferation to apoptosis 9.23a ±5.71 7.08ab ±3.02 6.58b ±2.80 0.021kw 
Total-cell proliferation to total-cell apoptosis 10.70a ±3.54 6.75b ±2.23 5.97b ±1.92 <0.001 
- Data presented as mean ± standard deviation (SD), ANOVA 
- 
kw
 = P-values from Kruskal-Wallis test  
- 
a, b, c
 mean values with different superscripts within the same row are different at P≤0.05; Tukey’s test or 
Behrens Fisher tests and Asymptotic Mann-Whitney tests  
- Morphometry: n= 2 or 4 (Ctrl) loops, 30 villi or crypt /loop; Values are mean numbers per villus or per 
crypt 
- Proliferation and apoptosis: n= 2 or 4 (Ctrl) loops, 20 villi or crypt/loop; Values are mean numbers per1/3 
villus tip or per 2/3 crypt base 
 
 
 
Table B3. 
Gene expressions of jejunal loops treated with 10-µM DON for 24-h in situ incubation. 
Genes Ctrl DON P-value 
IL-1α 1 ±0.786 0.999 ±0.243 0.998 
IL-1β 1 ±1.210 0.173 ±0.118 0.541 
IL-6 1 ±1.160 0.275 ±0.017 1.000w 
IL-8 1 ±0.666 0.393 ±0.187 0.498 
IL-21 1 ±0.807 0.994 ±0.936 0.961 
IL12-p40 1 ±0.205 0.703 ±0.460 0.642 
TGF-β 1 ±0.317 0.605 ±0.004 0.371w 
Claudin-4 1 ±0.233 0.642 ±0.126 0.132 
- Data presented as mean ± standard deviation (SD); n= 2 (pigs); Paired t-test 
- 
w
 = Wilcoxon matched pairs test 
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vivo and in vivo on pig intestinal mucosa 
 
Abstract 
 
Deoxynivalenol (DON) and nivalenol (NIV), major fusariotoxins and worldwide cereal 
contaminants, raise concerns for intestinal health. The impact of DON and NIV on pig intestinal 
mucosa was investigated after acute exposure on jejunal explants after 4 hours (0 to 10 µM), on  
jejunal loops after 4 hours and 24 hours (0 to 10 µM),  and after 28-day natural contamination 
feeding of  animals.  On explants, dose-dependent increases in the histological changes were 
induced. The decrease in the overall proliferative villus cells was concordant between animal 
experiment and loops, reaching after 4 hours in loops 13% and 30%, and after 24 hours 35 and 40 
% for DON and NIV respectively, at 10 µM. In loops, villus apoptosis increased after DON and 
NIV at 10 µM. After 24 hours, apoptotic enterocytes increased dose-dependently by DON, NIV, or 
the combination DON+NIV (1:1). The interaction analysis showed synergism between DON and 
NIV for villus enterocyte apoptosis. 
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RESUME : 
Déoxynivalenol (DON) et nivalénol (NIV), fusariotoxines majeures des céréréales peuvent 
endommager l’intestin. Les effets de DON et NIV sur la muqueuse intestinale ont été étudiés 
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histologiques dose-dépendantes ont été induites. In vivo, la diminution du nombre de cellules 
villositaires  en prolifération a été concordante pour les anses jejunales et chez les animaux, 
atteignant, pour DON et NIV respectivement, 13 et 30% après 4h, et après 24 heures 35% et 
40%, à 10 µM. Dans les anses, l’apoptose a été induite au niveau des villosités à 10µM de 
DON et de NIV. Après 24 heures, le nombre d’entérocytes apoptotiques a augmenté de façon 
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